AMERICAS HEPATO-PANCREATO-BILIARY ASSOCIATION … · 2018-07-08 · session organized by Sharon...

AMERICAS HEPATO-PANCREATO-BILIARY ASSOCIATION

FEBRuARY 20-24, 2013

Eden Roc Renaissance M i a M i B e ac h , F l o r i da

Annual Meeting 2013

Improving Patient Outcomes in H P B

Come by and see the new

Planning and Navigation at your fingertipsPathfinder Technologies offers state-of-the-art computer-assisted navigation and 3D

visualization for medical professionals, to enable more accurate and efficient delivery of cancer therapeutics in soft-tissue organs.

www.pathnav.com

PROOF 4

President’s Welcome letterI am delighted to welcome you to the Eden Roc for the 13th annual Congress of the Americas Hepato-Pancreato-Biliary Association. We return to our traditional Miami Beach home on the heels of a fabulously successful 2012 meeting, and we expect the 2013 meeting to bring us to new heights.

Our society is thriving, and the membership continues to grow, now numbering over 1,000. These changes speak volumes about the quality of the educational program offered at our annual meeting and other AHBPA sponsored events, but they also reflect the hard work and dedication of many of our members and our Executive Director, Kim O’Dell, and her staff.

We have also actively engaged our colleagues in Central and South America, and their greater participation in our meetings and their involvement in the AHPBA have made us much stronger.

Todd Bauer and his committee, with input from others, have created an outstanding program, with a wide array of educational opportunities. William Chapman, our President-Elect, has organized a superb Postgraduate Course that combines lectures on selected topics and case presentations. This year’s meeting will see the continuation of several events that were very successful at last year’s meeting: the Ultrasound and Advanced HPB Technology course on Wednesday (directed by Ellen Hagopian), the Fellows’ Symposium, (thanks to the efforts of Rohan Jeyarajah and Paul Hansen), and the AHPBA historical lecture (this year’s speaker: Howard Reber). New this year is a session organized by Sharon Weber that will explore how the AHPBA can promote and support the performance of clinical trials, a focus of activity that we hope will become increasingly important for our society. Leslie H. Blumgart will offer colorful insights into the evolution of our specialty as this year’s invited presidential lecturer. The social program, including the annual golf and fishing tournaments and the members’ banquet, will afford attendees an opportunity to interact in more informal settings.

Over the years, Kim O’Dell’s diligent management of every detail of our annual meeting has been reflected in the high quality of the final product, and this year is no exception - I thank her for her dedicated efforts. I extend thanks also to the Development Committee and other members who participated in continuing medical education grant writing and recruitment of sponsors for the meeting this year. My deep personal gratitude goes to the AHPBA officers and all the members of the Executive Council who have given selflessly of their time during the past year to conduct the association’s affairs and ensure its continued success. Our past presidents and others in leadership roles deserve special recognition for the strong foundation they created, on which our current success is built. Please be sure to offer all of the hard working members of our organization your thanks. Finally, we are all indebted to our corporate partners who have graciously and generously provided their support. Please visit the Exhibit Hall throughout the meeting to learn about our sponsors and personally thank them for participating and supporting our efforts.

As the AHPBA continues to grow and mature as an organization, we are now positioned to take a leading role in the field of HPB surgery, from setting standards for clinical care and providing CME to our members, to the training and education of residents and fellows and support of ground-breaking research. In order for us to achieve this goal, our members must be engaged and active. Your participation is vital to the ongoing success of the society, and I hope that this meeting provides the spark of inspiration for you to become more involved in helping shape the AHPBA’s future.

It has been a pleasure and privilege to serve the AHPBA this year and in the past.

Enjoy the meeting.

William R. Jarnagin, M.D.

Improving Patient Outcomes in HPB

AHPBA 2013Annual Meeting

1

PROOF 4

2013 sPonsorsThe AHPBA wishes to thank the following organizations for their support of the 2013 Annual Meeting.

Former ly Sa l ient Surg ica l Technolog ies

educational Grant Provided by

Platinum level

Gold level

silver level

bronze level

General meetinG suPPort

T E C H N O L O G I E SVisualization | Planning | Navigation

Kyoto Kagaku Co. Ltd.


AHPBA 2013

2

13th Annual Meeting

executive council officersPresident: William R. Jarnagin, MDPresident-Elect: William C. Chapman, MDSecretary: Javier Lendoire, MDTreasurer: Elijah Dixon, MD

members at larGeJeffrey Barkun, MDCarlos Chan, MDMichael A. Choti MD, MBASean P. Cleary, MDFelipe Jose Fernandez Coimbra, MDMichael D’Angelica, MDXabier Ander de Aretxabala, MDMichael B. Farnell, MDCraig Fischer, MD, MPH, FACSDavid A. Iannitti, MD, FACSRobert C.G. Martin, MDSusan L. Orloff, MD

Past PresidentsImmediate Past President: Jean-Nicolas Vauthey, MD

Past President: Reid B. Adams, MD

committee chairsCETAT Jim Moser, MD

DevelopmentHoracio Asbun, MD

Education & TrainingRebecca Minter, MD

Finance Elijah Dixon, MD

HPB Program Directors D. Rohan Jeyarajah, MD FACS

International Relations Gazi B. Zibari, MD

MembershipFelipe José Fernández Coimbra, MD

Professional DevelopmentJohn Christein, MD

ProgramTodd Bauer, MD

PublicationsTimothy M. Pawlik, MD, MPH, FACS

Research CommitteeSharon Weber, MD

ex-officio Foundation President: W. Scott Helton, MD

ahPba Past PresidentsJean-Nicolas Vauthey, MD 2011 - 2012 Reid B. Adams, MD 2010 - 2011 W. Scott Helton, MD 2009 - 2010 Mark P. Callery, MD 2008 - 2009 Bruce D. Schirmer, MD 2007 - 2008 Sean J. Mulvihill, MD 2006 - 2007 Theodore Pappas, MD 2005 - 2006

C. Wright Pinson, MD, MBA 2003 - 2005 Steven M. Strasberg, MD 2001 - 2003 Henry A. Pitt, MD 1999 - 2001 William C. Meyers, MD 1997 - 1999 J. Michael Henderson, MD 1995 - 1997

ahPba leadershiP

Annual Meeting

3

PROOF 4

ahPba officeExecutive Director: Kim O’Dell, CMP - [email protected]/Database: Mindy Hoo - [email protected]/Sponsorship/Advertising: Latisha Moore - [email protected]: Debbie Batchelor - [email protected]

staff committee liaisons Publications, Research, HPB Program Directors: Lyn Henderson, CMPDevelopment, Membership: Latisha MooreEducation & Training, Finance, Program, Development: Kim O’Dell, CMPProfessional Development, Publications: Lane WadsworthCETAT, International Relations: Bobby Davis

ProGram committee

Todd W. Bauer, MD2013 Program Chair

Todd W. Bauer, MD - ChairBryan Clary, MD - Vice/Co-Chair Chad G. Ball, MDStephen W. Behrman, MD, FACSNicholas Jarupe Cassis, MDClifford Cho, MDQuyen Chu, MDYun Shin Chun, MDThomas E. Clancy, MDRobert E. Glasgow, MDWilliam G. Hawkins, MDPamela Joy Hodul, MDEugene Paul Kennedy, MDMilan Kinkhabwala, MDSean Kumer, MD, PhDJennifer Lafemina, MDAjay Maker, MDSatish N. Nadig MD, PhDAttila Nakeeb, MDPurvi Parikh, MDFlavio Rocha, MD

Sharona Ross, MD Norberto J. Sanchez, MDCourtney Scaife, MDThomas Schnelldorfer MD, FACSCharles R. Scoggins, MDMargo C. Shoup, MDConrad Simpfendorfer, MDChristopher Sonnenday, MD Kevin F. Staveley-O’Carroll, MD, PhDLee Thompson, MD Allan Tsung, MDBrendan C. Visser, MDCharles M. Vollmer, MD Emly R. Winslow, MDNicholas J. Zyromski, MD

Ex-OfficioWilliam Jarnagin, MDKim O’Dell, CMP


AHPBA 2013

4

13th Annual Meeting

ahPba foundation donorsWe are proud to recognize our donors and would like to thank all of the Organizations and Individual Supporters whose continued generosity allows us to promote the research on diseases of the liver, pancreas and biliary tract.

DIAMONDAHPBA

GOlDReid AdamsMark Callery

William ChapmanSean Cleary

Michael D’AngelicaElijah Dixon

O James GardenPaul Greig

William Helton

David IannittiWilliam JarnaginMichael JacobsKeith LillemoeAndrew Lowy

Rebecca MinterMichele Molinari

Sean MulvihillSusan Orloff

C. Wright PinsonHenry Pitt

Charles Burke RosenBruce Schirmer

Roderich SchwarzJean-Nicolas Vauthey

Charles Vollmer Gazi Zibari

SIlverJohn Christein

Alessandro DinizDaniel Kleiner

Charles Vollmer

BrONzeJeffrey BarkunFelipe Coimbra

Purvi ParikhJuan Pekolj

Ponnandia SomasundarSteven StrasbergKevin Watkins

Thomas A. AloiaTodd Bauer

Yun Shin ChunBryan Clary

Wilson Luiz Costa Jr Douglas Evans Riad Haddad

D. Ryan Hall Ruth Haynes

Paulo HermanOscar Imventarza

D. Rohan Jeyarajah Javier LendoireMariano Moro

Attila NakeebMayank Roy

Margo Shoup Atsushi SugiokaRebekah White

Randall Zuckerman

CONtrIButOrS

Annual Meeting

5

PROOF 4

2013 ahPba distinGuished service aWard reciPient: henry a. Pitt, mdThe AHPBA Executive Council has voted to give the 2013 AHPBA Distinguished Service Award to Henry A. Pitt, MD, a founder of the association. Dr. Pitt is Vice Chairman of the Department of Surgery at the Indiana University School of Medicine. He not only helped the AHPBA and IHPBA get off the ground, but he is still heavily involved in activities that are moving the field to the next level.

“I am extremely honored to be appreciated by my peers for the work I have done to help people more broadly, which is why we do research and participate in societies,” Dr. Pitt said. “Research has the potential to help more than one person at a time, and AHPBA’s broad efforts in education and training can help many, many people in our region and beyond.”

Dr. Pitt grew up Union, NJ, and went to Cornell University for his undergraduate degree and medical school. He then trained in surgery at Johns Hopkins. His first academic job was at UCLA in 1979-85, where he focused on hepato-pancreato-biliary surgery with Bill Longmire as his mentor.

“When I was a resident in the 1970s, the type of surgery we do today—pancreatectomies and hepatectomies--were not being done that often,” he said. “But I was exposed to patients with bad pancreatitis, and the occasional patient who needed the kind of surgery we do today. I could see that the superspecialty of HPB was going to emerge. At that time, the only two places to train were with Henri Bismuth in Paris and with Dr. Longmire in Los Angeles. I didn’t speak French, so going to UCLA made more sense.”

Dr. Pitt is also a historian of the field of HPB and is writing a book on the subject. He witnessed and participated in the coalescence of today’s leading organizations in the field of HPB surgery.

“In early ‘80s at UCLA, the whole HPB movement was just beginning, and the first thing that happened was the creation of the International Biliary Association in 1979. Cardiac surgery had evolved into a superspecialty, vascular surgery was evolving, surgical oncology was beginning, and so was HPB. The first president of the IBA was Ronald Tompkin, a surgeon at UCLA with whom I worked. He suggested that I attend the first international meeting in Paris in 1980. At that meeting I met Henri Bismuth. Drs. Longmire and Tomkins also introduced me to other leaders in the field, many of whom were European, for example, Les Blumgart, from England at that time, and Stig Bengmark from Sweden.

“The IBA became the IHBPA in late ‘80s, and then in 1994, it became the IHPBA. We then began to work to create the AHPBA. Three people were the “founders” of the AHPBA: Bill Meyers, at Duke at the time; Mike Henderson of the Cleveland Clinic; and me. I was at Johns Hopkins having moved back there as Vice Chair of the Surgery Department in 1985. To get the AHPBA off the ground, we had some preliminary meetings in the mid-1990s, which were associated with the AASLD—the American Association for the Study of Liver Diseases, and the American Pancreatic Association. Initially we put on postgraduate courses during the AASLD meetings.

“The first meeting of the AHPBA took place in 1997, and Mike Henderson was the first president. Bill Meyers was President-Elect, and I was Secretary. We met at The Doral Golf Resort and Spa in Miami. Wes Harrington served as our first meeting organizer and was the Congress Secretariat. Ted Pappas was the first Chairman of the Scientific Program Committee, and Bill Meyers was chair of the Organizing Committee. Mike, Bill, Ted, Wes and I organized the first meeting with no money in the bank. However, we raised money from industry, and invited a lot of faculty from the Americas. From the very beginning, we tried to make this a regional association. We started out having congresses every other year, and now we meet annually. When Ted Pappas was president, he decided that we should have an annual Americas Congress, which was a great decision.”

Henry A. Pitt, MD


AHPBA 2013

6

13th Annual Meeting

Dr. Pitt could not be more pleased at how extensively the association has developed from its humble beginnings. “It’s fabulous the way the AHPBA has evolved in just 18 years. It’s wonderful. I was president of the AHPBA in 2001, and subsequently president of IHPBA in 2006. The idea of developing the three regions within the IHPBA was something that Joseph Lau from Hong Kong and Jim Toouli from Australia and I worked on. Joseph was president of the IHPBA, followed by Jim, followed by me. The idea of the AHPBA being a regional association was a goal from the beginning, though the Association evolved initially, primarily in North America. As some of us worked to build the regions through the IHPBA, others got involved to make the AHPBA a regional association. As AHPBA president, Sean Mulvihill oversaw the decision to support the IHPBA meeting in Argentina, and Scott Helton and Mark Callery as presidents of the AHPBA really reached out further to Central and South America.”

Dr. Pitt is president of the IHPBA Kenneth Warren Foundation, and heavily involved in the ACS-NSQIP initiative. “Ken Warren was a surgeon from Boston, and the goal of the IHPBA foundation is to foster HPB research at an international level. The person who receives the Warren Fellowship needs to be from one country, but does research in another country. Quite a few of the mentors for the Warren Fellows have come from the AHPBA, and several recipients have come from Central and South America. We have supported the Fellows for more than a decade and given out more than $200,000.

Dr. Pitt is very proud of the role the AHPBA has taken in fostering research, overseeing training and improving surgical outcomes across the profession.

“We’ve always had HPB research as a stated goal for the AHPBA. Clearly, the main mission of the association is education. However, fostering research has been another major mission. Something that has evolved in the last seven or eight years has been for the AHPBA to foster HPB training. As the super-specialty of HPB has emerged, training our successors has become a very important mission, which has evolved very nicely.

“The other area that always has been a goal, but has never come fully to fruition, is for the AHPBA to oversee multi-center trials and to create registries. The role of improving quality in HPB surgery is another emerging goal. I have been working with the American College of Surgeons on the National Surgery Quality Improvement Program (NSQIP). This past year we have worked on the Pancreatectomy Demonstration Project within NSQIP. The AHPBA Research Committee has developed HPB-specific variables to add to NSQIP. Our Pancreatectomy Demonstration Project has implemented those variables at 48 hospitals this past year, including most of the major pancreatectomy centers. We are gathering data on about 25% of all the pancreatectomies performed in the US. The goal is to feed back data to improve outcomes via NSQIP-HPB,” he said.

“Multi-center randomized trials could use NSQIP-HPB as a data repository. A clinical question could be asked to test two different ways of doing an operation to determine which is the best. A group of us published a paper regarding NSQIP-HPB in HPB in 2009. This position paper included Mike Henderson, Sean Mulvihill, Steve Strasburg, Past-Presidents of the AHPBA, as well as members of the AHPBA Research Committee, including Tom Aloia, Elijah Dixon, Tim Pawlik and Nick Zyromski.

“Over the time I have been an HPB surgeon, the mortality of our operations has come down very nicely, though morbidity remains very high. With NSQIP-HPB the goal is to reduce the complications associated with pancreatectomies and hepatectomies. The mortality is less than 5%, but the morbidity remains 40-50%, and we should be able to reduce morbidity over the next decade. A marriage between the AHPBA and ACS-NSQIP would be a great next step for our Association.”

Annual Meeting

7

PROOF 4

ahPba 2012 travelinG felloWshiP reciPientsthomas a. aloia, mdDestination: Chile

I was very fortunate to be awarded one of the AHPBA 2012-13 Travelling Fellowships. With this generous award I planned a trip to Southern Chile. The education focus of the trip was to study the epidemiology, staging, and multidisciplinary treatment of gallbladder cancer. Although rare in North America, it has been well documented that the incidence of this devastating disease in Southern Chile is the highest in the world. To accomplish

this goal I was able to partner with several of the outstanding HPB units in Santiago and the surrounding area.

During the two week trip, in Santiago, I visited Clinica Alemana, Catholic University, and the HC San Borja Arriaran public hospital. In a side trip to Temuco, Chile (the gallbladder cancer capital of the world) I visited the Clinica Alemana Hospital and the Universidad de la Frontera. I attended multiple tumor boards, operations, trainee rounds, and lectures. Combined this exposure gave me many new insights into the management of this disease and future ideas for investigation regarding both systemic and surgical therapies.

I am indebted to my hosts who gave so much of their time and energy to this trip. Many welcomed me into their homes and gave me a true sense of the vibrant life of Santiago and Chile in general. Many thanks to Xabier de Arexabala, Nicolas Jarufe, Juan Hepp, Jorge Leon, Carlos Benevides, Hector Losada, Luis Fonseca, Jorge Silva, Luis Borgos, Juan Francisco Guerra and many others. Thanks are also due to the AHPBA Research Committee, Executive Committee, and Executive Directors for supporting this once-in-a-lifetime opportunity.

flavio G. rocha, mdDestination: Hospital das Clinicas Universidade de Sao Paulo, Brasil

It was a sincere pleasure to visit the Liver Unit at the Hospital das Clinicas in Sao Paulo headed by Dr. Paulo Herman. As a Brazilian trained exclusively in the United States, the purpose of my visit was two-fold. First, I wanted to observe the training and delivery of specialized hepatobiliary surgery in one of the major referral centers in my native land. Second, I had the

opportunity to learn the open and minimally invasive techniques for intrahepatic Glissonian pedicle control during major hepatectomy popularized by Dr. Herman’s group. During my visit, I met with the staff from the hepatobiliary, pancreatic and transplant divisions at both HC/USP and Hospital Sirio-Libanes, observed a variety of complex HPB procedures, discussed cases at their tumor board and toured their laboratory facilities. I was impressed with the breadth of their cases, the integration of trainees at all levels and the dedication to research throughout the medical center. I am indebted to the AHPBA Research Committee and Executive Council for sponsoring this wonderful opportunity. I would also like to thank Drs. Paulo Herman, Luiz Carneiro, Marcos Perini, Fabricio Coelho, and Jaime Kruger who generously took time away from their busy academic practice to host me during this visit to the metropolis of Sao Paulo.


AHPBA 2013

8

13th Annual Meeting

SuPPoRTED In PART By AHPBA FounDATIon

the ahPba foundation is proud to support three international travel

exchange awards each year.

the 2013 travel exchange application deadline is april 1, 2013.

lucas mccormack, mdDestination: Toronto General Hospital, Canada.

I am very honored by the AHPBA Research Committee after being selected as a candidate for the 2012-2013 Travelling Fellowship award. As a consequence of this generous support, I had the opportunity to visit the multi-disciplinary HPB and Liver Transplant Program at the Toronto General Hospital in Toronto, Canada. Hosted by the superb surgeon, excellent musician and wonderful person, Dr. Paul Greig, I had the pleasure to observe “from inside” how a first class HPB unit works in a multidisciplinary

manner and exports excellent surgeon to all over the world.

Over the course of my visit, I had a very strict schedule! I attended to many educational regular activities (transplant rounds, tumor boards, seminars, conferences), complex operations and transplants, and also many social events (dinners & drinks). As an important goal of my visit was “HPB and surgical education,” I enjoyed visiting the famous Wilson Center for Education Research hosted by Carol Anne Moulton and the Surgical Skills Center form the University of Toronto to train residents and fellows. I was able to spend many hours with each HPB and transplant fellow and with each of the staff members talking with them about their goals and plans for the future. It was incredibly rewarding to be able to discuss common issues regarding how to improve patient care and education in HPB and transplantation.

I truly appreciate the confidence that Paul Greig showed in me by accepting me for this visit and by opening the doors of his program and house during my stay. I also acknowledge the HPB surgical team composed by “his international fellows” and all the other staff-partners, especially to Markus and Nazia Selzner, Alice Wei, Sean Cleary, Carol Anne Moulton, Steven Gallinger, Anand Ghanekar and Ian McGilvray. Each person’s advice and experience has been tremendously helpful throughout this one-week visit in Toronto.

I am convinced that this was a wonderful experience, and made me even surer that we should develop further our HPB & Transplant fellowship to try to mimic in Argentina the Toronto experience on building excellent surgeons in the HPB field.

Annual Meeting

9

PROOF 4

michele babicky, 2011 reciPient From the laboratory of andy lowy, University of california San diego

TarGeTiNG The roN TYroSiNe KiNaSe recePTor iN PaNcreaTic caNcer

Research Synopsis: Our laboratory focuses on the role of the RON Receptor Tyrosine Kinase in pancreatic carcinogenesis. We have previously demonstrated that RON overexpression confers apoptotic resistance in pancreatic cancer, and that down-regulation of this receptor can sensitize cancer cells to gemcitabine treatment. In this project, I have evaluated the effect of a novel RON inhibitor on tumor growth using a patient-derived orthotopic xenograft model. The inhibitor, RON-8, is a human monoclonal antibody directed against the RON receptor that is currently in Phase I clinical trials. We compared the efficacy of this agent, both alone and in combination with gemcitabine.

We screened eleven unique patient-derived xenografts for sensitivity to RON-directed therapy. In this model, one tumor treated with RON8 exhibited significant growth inhibition compared with IgG control. A phospho-RTK array revealed that the RON8 sensitive tumor expressed phosphorylated RON receptor. The PDX model is highly sensitive to Gemcitabine therapy, a result that is not observed in cell line injection models.

The PDX model can be used to screen human tumors for sensitivity to targeted therapies. Tumors that demonstrate growth inhibition after treatment with targeted agents may be used to identify potential biomarkers that may be predictive of therapeutic response. This approach may help guide patient selection for clinical trials in the future, thus providing a more accurate evaluation of the potential efficacy of new therapeutic agents. Patient-derived xenografts appear to be highly sensitive to Gemcitabine, thereby limiting the predictive value of this model in determining potential synergy with targeted agents.

ahPba research aWard uPdate


AHPBA 2013

10

13th Annual Meeting

kevin c. soares, 2012 reciPient

Combinatorial Immunotherapy And The Manipulation of Tumor Microenvironment In The Treatment of Pancreatic Cancer

Research Synopsis: It is my pleasure to present an outline and update of my research project entitled “Combinatorial immunotherapy and the manipulation of tumor microenvironment in the treatment of pancreatic cancer.” Our phase I/II human clinical trials utilizing a GM-CSF secreting allogeneic pancreas tumor

vaccine (GVAX) have been shown to be safe and effective in inducing anti-tumor immune response in pancreatic adenocarcinoma patients. GVAX treated patients have demonstrated infiltration of PD-1+ T cells, which is a major immunosuppressive mechanism in the tumor microenvironment. We hypothesized that the use of a PD-1 blocking antibody and GVAX will improve vaccine therapy and pancreatic cancer survival. The primary objective of this study was to determine if manipulation of the tumor microenvironment by the blockade of the programmed cell death 1 receptor used with a GM-CSF secreting pancreatic tumor vaccine will enhance Annexin specific T cell responses and survival in a novel murine hepatic metastasis pancreatic cancer model.

Mice were orthotopically transplanted with Panc02 pancreatic tumor cells to form liver metastases by a hemisplenectomy technique followed by treatment with a mouse GM-CSF secreting pancreatic tumor vaccine (mouse GVAX) in combination with anti- PD-1 antibodies or IgG isotype control. Survival analysis demonstrated a statistically significant survival advantage with both anti-PD-1 alone (p=0.008) or in combination with vaccine (p<0.0001) versus IgG controls (Fig. 1). Murine GVAX has been demonstrated to induce mesothelin specific CD8+ T cells in the peripheral blood and the exact epitopes have been identified. We conducted mesothelin specific intracellular staining on CD8+ tumor infiltrating lymphocytes (TILs) with these known mesothelin epitopes and demonstrated a higher percentage of mesothelin-specific cytotoxic CD8+ TILs in the combination treatment group (GVAX and anti-PD1 therapy) versus GVAX alone (13.4% vs 5.29%).

PD-1 blockade through monoclonal antibodies in combination with vaccine result in a synergistic anti-tumor effect in a preclinical model of pancreatic cancer versus treatment with anti-PD1 alone. Additionally, anti-PD1 treatment facilitates tumor infiltration of functionally activated mesothelin specific CD8+ T cells. Our future directions include identification of the annexin epitope and annexin specific intracellular staining demonstrating enhanced infiltration of annexin specific cytotoxic CD8+ TILs. Additionally, programmed cell death ligand 1 (PD-L1) antibodies will be tested in combination with GVAX and/or PD-1 antibodies and assessed for improved anti-tumor effect.

Thank you very much for recognizing my research project and the 2012 AHPBA Research Fellowship Grant. The AHPBA’s support has been instrumental in helping me to achieve this project’s goal and I look forward to presenting my final summary at the AHPBA annual meeting in 2014.

ahPba research aWard uPdate

Annual Meeting

11

PROOF 4

ahPba chaPtersarGentina

The Argentinian Chapter of the IHPBA was formed on April 24, 1995, led by Eduardo de Santibanes. The chapter currently has 337 members. Ricardo Bracco, MD, is the chapter President for 2013.

The Argentinian Chapter holds an Annual Meeting, which will next take place on April 25-28, 2014. The association provides educational opportunities via active support of HPB courses, educational meetings, and fellowships. In April 2010, the IHPBA held its ninth World Congress in Buenos Aires, a very successful event despite a volcanic eruption in Iceland keeping some speakers

and attendees from participating.

brazilThe Brazilian Chapter of International Hepato-Pancreato-Biliary Association (CB-IHPBA), founded in 2001, has approximately 300 members and is currently reorganizing its membership list. CB-IHPBA has organized a biannual meeting in years alternating with the year of the World Congress since 2003. The association helps to provide any educational opportunity in its member hospitals, but is working to get this program fully operational. The current president is Carlos Eduardo R. Santos, MD, PhD.

chileThe HPB Department of the Chilean Surgical Society was created in 2006. This association has more than 50 active members, many of them AHPBA members. The chapter is committed to disseminating the best treatment practices between its members and the Chilean surgical community, and encourages a multidisciplinary approach to HPB diseases. The chapter maintains several academic activities during the year, including keynote lectures, video sessions, roundtables, and case discussions. At the Annual Congress of the Chilean Surgical Society, held in November of each year, the chapter organizes and leads a workshop of the specialty that helps

participants gain advanced education, share experiences, and promote the best standard of care for HPB patients. The current president is Hernan de la Fuente, MD. The chapter website can be found at www.cirujanosdechile.cl.

ecuadorIn June 2004, Dr. Nestor Gomez talked to Dr. Wright Pinson in Washington DC, about the possibility of founding an AHPBA Ecuadorian chapter. After further studies and deliberations, the chapter was founded with nine members on May 24, 2006. Today, the Ecuadorian chapter has 15 active members.

The association has conducted a meeting every two years in the Galapagos Islands. The first Congress was held September 12-15, 2007, under the chairmanship of Dr. Nestor Gomez. The second Congress was held from September 8-10, 2011 under the chairmanship of Dr. Pedro Barberán. That

year, Dr. Gomez hosted a very successful AHPBA charity mission of HPB surgeons led by Dr. Gazi Zibari. This year’s Congress will be held on September 12-15, 2013 under the chairmanship of Dr. Eduardo Rivas.


AHPBA 2013

12

13th Annual Meeting

ahPba reGistration desk hoursLocation: Ocean Tower I Foyer

Wednesday 6:30 – 8:30 pmThursday 6:30 am – 6:00 pmFriday 6:30 am – 5:00 pmSaturday 7:00 am – 5:00 pmSunday 7:30 – 11:00 am

sPeaker ready room hoursLocation: San Marco (lower conference rooms of the hotel)

Wednesday 6:00 – 8:00 pmThursday 6:30 am – 6:30 pmFriday 6:30 am – 5:30 pmSaturday 7:00 am – 5:00 pmSunday 7:30 – 11:00 am

ahPba foundationStop by the registration desk and donate to the Foundation today!

meetinG videos available for PurchaseMEDCALDTV will be on-site video taping the meeting. If you would like to order a copy, you may do so onsite or take an order form with you.

a Gentle reminderEvery precaution to assure the safety and security of our attendees and their guests has been taken. However, we urge you to be aware and take simple steps to guard your possessions. • Do not leave your purse or briefcase unattended. • Do not leave your laptop, phone or PDAs on the floor or out of your sight. • Be aware of your surroundings.

If you do misplace or lose something, please let someone at the Registration Desk know immediately.

cme certificates & conference evaluationsAll attendees will receive their CME and Attendance Certificates by completing the evaluations online. You will receive an email (using the email that you registered with for the conference and listed on your registration envelope) explaining how to complete your evaluation. If you have not received this email by the end of the meeting, please let someone at the AHPBA Registration Desk know. You will not need to contact anyone to send you your certificate, as you will be able to print your own as soon as you complete your online evaluation. However, should you experience any problems with the evaluation either during or after the Congress, please contact Kristi at [email protected] or 407-647-8839.

Onsite registrants: Your email will come at a later date.

Annual Meeting

13

PROOF 4

cme accreditation statementThis activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CMI Education Institute, Inc. and the Americas Hepato Pancreato Billiary Association (AHPBA). CMI Education Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

ama Pra desiGnation statementThe CMI Education Institute, Inc. designates this educational activity for a maximum of 39.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician assistantsAAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME. Physician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing the Allied Heath Symposium.

ada statementIn accordance with the ADA, the CMI Education Institute, Inc. and the AHPBA will accommodate requests of special needs made in advance of the meeting, in writing.

allied health symPosium AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category 1 Credit for completing this program.

ama Pra desiGnation statementThe CMI Education Institute, Inc. and the joint sponsor, AHPBA, will maintain full control of all aspects of the accredited CME activity titled: “the Americas Hepato-Pancreato-Biliary Association 2013 Annual Meeting” in accordance with ACCME.

learninG objectives and outcomesThe AHPBA 2013 Annual Meeting has been structured around six tracks. These represent the liver, pancreas, biliary system, liver transplantation, imaging and biomedical engineering, and general hepatobiliary (HPB) surgical disease. At the conclusion of the 2013 Annual Meeting of the AHPBA, the Association expects its attendees to have gained knowledge and skills that will lead to changes or enhancements in their own practices and improve physician training. The AHPBA expects that the 2013 Scientific Program’s educational interventions will result in measurable improvements in patient care.


AHPBA 2013

14

13th Annual Meeting

exhibit hallhoursThursday, February 21 5:15 - 6:45 pmFriday, February 22 9:30 am - 7:15 pmSaturday, February 23 6:30 am - 12:00 pm

Poster session hoursFriday, February 22 5:00 - 6:30 pmSaturday, February 23 6:15 - 7:45 pm

scheduled events in the exhibit hallTHuRSDAy, FEBRuARy 21

5:15 - 6:45 pm Welcome Reception

FRIDAy, FEBRuARy 22

10:10 - 10:45 am Morning Break1:15 - 2:15 pm Lunch4:45 - 5:00 pm Afternoon Break6:30 - 7:15 pm Cocktail Reception

SATuRDAy, FEBRuARy 23

6:30 - 8:00 am Breakfast with the Exhibitors

exhibit hall video PresentationsFri, Feb 22, 10:10-10:45 amEddie Abdalla, MD“ Left Hepatectomy With Caudate Lobectomy And Extrahepatic Bile Duct Resection.”

Fri, Feb 22, 1:15-1:45 pmHoracio Asbun, MD“Laparoscopic Distal Pancreatectomy: Tips, Tricks and Pitfalls.”

Fri, Feb 22, 1:45-2:15 pmPeter Kingham, MD“Laparoscopic Liver Resection: Tips, Tricks, and Pitfalls.”

Fri, Feb 22, 6:30-7:15 pmWill Chapman, MD“Use Of Transplant Techniques For Complex Hepatic Resection.”

Sat, Feb 23, 7:00-7:30 amAlan Hemming, MD“Minimally Invasive To Maximally Invasive Liver Surgery - From Robotics To Vascular Reconstruction.”

Sat, Feb 23, 10:45-11:15 amIan McGilvray, MD“Hepatic Resection With Hepatic Vein Reconstruction: How And When?”

Annual Meeting

15

PROOF 4

maintenance of certification MOC Maintenance of Certification offered for the following sessions. The post test will be available online after the course.

THuRSDAy, FEBRuARy 21, 2013 - PoST GRADuATE CouRSE - 4.5 HouRS ToTAl

9:30 - 11:00 AM Liver/Biliary - 1.5 11:00 AM - 12:30 PM Transplant - 1.52:00 - 3:30 PM Pancreas - 1.5

FRIDAy, FEBRuARy 22, 2013 - 4.5 HouRS ToTAl

10:45 - 11:15 AM Parallel State of the Art Lectures .5 hours 11:15 AM - 1:15 PM Parallel Symposia - 2 hours2:45 - 3:15 PM Historical Lecture - .5 hours3:15 - 4:45 PM Parallel Symposia - 1.5 hours

SATuRDAy, FEBRuARy 23, 2013 - 8 HouRS ToTAl

10:00 -10:45 AM Parallel Update - .75 hours11:15 AM - 12:00 PM Parallel Debate - .75 hours12:00 - l:00 PM Sequential State of the Art Lectures - 1 hourl:00 - 2:00 PM Educational Lunch Symposia - 1 hour2:45 - 3:45 PM Volunteerism and Humanitarian Outreach Symposium - 1 hour3:45 - 4:30 PM Parallel Debates - .75 hours4:30 - 5:15 PM Parallel Update Lectures - .75 hours7:30 - 9:30 PM Educational Dinner Symposia - 2 hours

SunDAy, FEBRuARy 24, 2013 - 3 HouRS

7:30 - 8:30 AM Parallel Competitive Videos - 1 hour8:30 - 9:30 AM Committee on Surgical Innovation (CSI) Symposium - 1 hour9:30 - 10:30 AM Special Lecture - How Many HPB Surgeons Do We Need? Results of

a National Workforce Survey - 1 hour

audience resPonse ARThis interactive feature will be available out of the Ocean Tower I Ballroom. Handsets will be distributed throughout the room.

THuRSDAy … EnTIRE PoST-GRAD CouRSE

FRIDAy

10:45 am State of Art Lecture 11:15 am Social Media Symposium 3:15 pm AHPBA-led Clinical Trials Symposium

SATuRDAy

10:00 am Update Lecture 11:15 am Debate 12:00 pm SOA Lecture2:45 pm Volunteerism/Outreach Symposium 3:45 pm Debate 4:30 pm Update Lectures


AHPBA 2013

16

13th Annual Meeting

2012 HPB CertIFICAteS OF COMPletION reCIPIeNtSCongratulations to the following members who have successfully completed their fellowship training and have fulfilled the surgical curriculum requirements, as set forth by the AHPBA and Fellowship Council.

These individuals will be recognized at the beginning of the President’s Plenary session.

Jon Cardinal University of Pittsburgh Medical Center

Sabini Zani Duke University Medical Center

Clancy Clark Mayo Clinic

Eugene Ceppa Indiana University

Osama Hamed Penn State College of Medicine

Ray Wong Medical College of Wisconsin

Kamran Idrees Washington University School of Medicine

Yiing Lin Washington University School of Medicine

HPB/ASTS Joint Certificate

Mohammad Jamal McGill University

Peter Kim The University of Toronto

Jean-Francois Ouellet University of Calgary

Ryan Swan Carolinas Medical Center

Pippa Newell Providence Portland Medical Center

Veerajah Siripurapu Methodist Dallas Medical Center

Charles R. St. Hill University of Louisville

Annual Meeting

17

PROOF 4

sPeakers & facultyDavid AdamsMedical University of South Carolina

Reid AdamsUniversity of Virginia Health System

Syed AhmadUniversity of Cincinnati

Peter AllenMemorial Sloan-Kettering Cancer Center

Thomas Aloia The University of Texas MD Anderson Cancer Center

Christopher AndersonUniversity of Mississippi Medical Center

Horacio AsbunMayo Clinic Florida

Jean Francois AubryUniversity of Virginia

Chad BallUniversity of Calgary

Jeffrey BarkunMcGill University

Stephen BehrmanUniversity of Tennessee Health Science Center - Memphis

Kevin BehrnsUniversity of Florida

Jacques BelghitiHospital Beaujon

Eren BerberThe Cleveland Clinic Foundation

Trey BlazerDuke University

leslie BlumgartMemorial Sloan-Kettering Cancer Center

luiz Carneiro D’AlbuquerqueUniversity of Sao Paulo

Eugene CeppaIndiana University School of Medicine

Carlos ChanInsituto Nacional de la Nutricion Salvador Zubiran

William ChapmanWashington University School of Medicine

Kevin CharpentierBrown University

Clifford ChoUniversity of Wisconsin School of Medicine and Public Health

John Christein University of Alabama at Birmingham

Christopher ChristophiAustin Hospital

Quyen ChuLouisiana State University Health Sciences Center - Shreveport

yun Shin ChunFox Chase Cancer Center

Thomas ClancyBrigham & Women’s Hospital

Bryan ClaryDuke University Medical Center

natalie CoburnUniversity of Toronto

Felipe CoimbraHospital Ac Camargo

Carlos CorveraUniversity of California San Francisco

James CostelloUniversity of Arizona

Gregory CoteIndiana University Hospital

Michael D’Angelica Memorial Sloan-Kettering Cancer Center

Xabier de AretxabalaUniversidad De Chile

Sebastian de la FuenteUniversity of Central Florida, Florida Hospital


AHPBA 2013

18

13th Annual Meeting

Eduardo de SantibanesHospital Italiano De Buenos Aires

Carlos Fernandez del CastilloMassachusetts General Hospital

Meghan DierksMassachusetts Institute of Technology

Elijah DixonUniversity of Calgary

M.B. Majella DoyleWashington University School of Medicine

Ariel DuboseLouisiana State University n. Joseph EspatRoger Williams Hospital

Douglas Evans Medical College of Wisconsin

Stan FinkelsteinMassachusetts Institute of Technology

James FrazierNorton Healthcare

Steven Gallinger University of Toronto / University Health Network

T. Clark GamblinMedical College of Wisconsin

o. James GardenUniversity of Edinburgh

Jenna GatesHospital of the University of Pennsylvania

David GellerUniversity of Pittsburgh Medical Center

Robert GlasgowThe University of Utah

nestor GomezUniversity of Guayaquil

Gregory GoresMayo Clinic

Vijaya Gottumukkala MD Anderson Cancer Center

Dirk GoumaAMC

Paul GreigUniversity of Toronto

niraj GusaniPennsylvania State College of Medicine

Ellen HagopianJersey Shore University Medical Center

Chet HammillProvidence Portland Medical Center

Arik Hananel Focused Ultrasound Surgery Foundation

Steven HanishEmory University

Paul HansenThe Oregon Clinic, Providence Medical Center

William HawkinsWashington University School of Medicine

Julie HeimbachMayo Clinic

W. Scott HeltonVirginia Mason Medical Center

Alan HemmingUniversity of San Diego at California

Paulo HermanUniversity of Sao Paulo Medical School

Pamela HodulMoffitt Cancer Center

Michael HouseIndiana University

Herbert HurwitzDuke University Medical Center

oscar ImventarzaHospital Argerich

Palepu JagannathLilavati Hospital

William JarnaginMemorial Sloan-Kettering Cancer Center

sPeakers & faculty

Annual Meeting

19

PROOF 4

D. Rohan JeyarajahSurgical Associates

Heather JonesUniversity of Pittsburgh Cancer Pavilion

Bobby KalbThe University of Arizona Medical Center

Ihab KamelJohns Hopkins Hospital

T. Peter KinghamMemorial Sloan-Kettering Cancer Center

Milan Kinkhabwala Montefiore Medical Center

David Kooby Emory University School of Medicine

Sean KumerUniversity of Kansas

Jennifer lafeminaUniversity of Massachusetts Memorial Medical Center

Javier lendoireHospital Dr. Cosme Argerich

David linehanWashington University School of Medicine

Shishir MaithelEmory University

Ajay MakerUniversity of Illinois at Chicago/Advocate Illinois Masonic Medical

lindsey Manos Johns Hopkins University School of Medicine

Robert MartinUniversity of Louisville

John MartinieCarolinas Medical Center

lucas McCormackHospital Aleman

Brian McGowanArcheMedx Inc.

Miguel-Angel MercadoInstituto Nacional De La Nutricion

Rebecca MinterUniversity of Michigan

Michele Molinari QEII Medical Centre

Katherine Morgan Medical University of South Carolina

A. James MoserBeth Israel Deaconess Medical Centre

Satish nadigUniversity of Michigan

David nagorneyMayo Clinic College of Medicine

Attila nakeebIndiana University Medical Center

Susan orloffOregon Health and Science University

Purvi ParikhAlbany Medical Center

Rowan Parks The University of Edinburgh

Timothy PawlikJohns Hopkins University

Juan PekoljHospital Italiano Buenos Aires Argentina

C. Wright PinsonVanderbilt University Medical Center

Henry PittIndiana University School of Medicine

Ronnie Tung-Ping PoonThe University of Hong Kong

Mitchell PosnerUniversity of Chicago

Kadiyala RavindraDuke University

Howard ReberUniversity of California, Los Angeles

sPeakers & faculty


AHPBA 2013

20

13th Annual Meeting

Srinevas ReddyUniversity of Maryland School of Medicine

Flavio RochaVirginia Mason Medical Center

Charles RosenMayo Clinic

Sharona RossFlorida Hospital Tampa

Courtney Scaife Huntsman Cancer Institute

Max SchmidtIndiana University School of Medicine

Beth SchropeColumbia University

Roderich Schwarz UT Southwestern Medical Center

Charles ScogginsUniversity of Louisville

Ketan ShethCambridge Health Alliance

Shailesh ShrikhandeTata Memorial Centre

Conrad SimpfendorferCleveland Clinic Florida

David SindramCarolinas Medical Center

Christopher SonnendayUniversity of Michigan

Kevin Staveley-o’CarrollPenn State Milton S. Hershey Medical Center

Ryan Swan Carolinas Medical Center

Melanie ThomasMedical University of South Carolina

lee ThompsonCancer Surgery of Mobile, P.C.

Mark Truty Mayo Clinic

Jennifer TsengBeth Israel Deaconess Medical Center

Allan TsungUniversity of Pittsburgh Medical Center

Kiran TuragaMedical College of Wisconsin

Jean-nicolas VautheyMD Anderson Cancer Center

Brendan VisserStanford University

Kevin WatkinsStony Brook School of Medicine

Sharon WeberUniversity of Wisconsin Hospital

Alice WeiUniversity Health Network, University of Toronto

Rebekah WhiteDuke University Medical Center

Emily WinslowUniversity of Wisconsin

Christopher WolfgangJohns Hopkins University School of Medicine

Gazi ZibariLouisiana State University Health Sciences Center-Shreveport

nicholas ZyromskiIndiana University

sPeakers & faculty

Annual Meeting

21

Optimal PatientCare through:education,

training,

research,

Innovation,

& Collaboration

MEMBERSHIP HAS ITS PRIVILEDGES

Join the AHPBA

PROOF 4

GoalsThe AHPBA is incorporated as a nonprofit organization and was created with vision of devoting itself to relieving the human suffering caused by HPB disorders throughout the world, by improving education, training, innovation, research and patient care.

1 Promote understanding of the causes of disorders of the liver, pancreas and biliary tree and to investigate and treat these diseases.

2 Encourage the exchange of clinical and scientific knowledge among surgeons and members of related disciplines working in the field.

3 Study any relevant problems that affect the liver, pancreas and biliary tract.

4 Facilitate collaborative research into the factors that lead to disease in these organs and into ways of preventing it.

5 Foster friendships among clinicians and scientists involved in the hepatic, pancreatic and biliary disciplines.

6 Strive towards the highest ethical standards in the Association’s fields of endeavor.

7 Foster education and career development in the field through an identifiable funding mechanism.

Membership BenefitsWe invite you to take part in our growing organization by becoming a member of the AHPBA. Membership in AHPBA connects you to a national and global network of medical professionals specializing in the liver, pancreas and biliary system. AHPBA boasts a diverse membership of more than 950 physicians, not only surgeons, but leading specialists within the fields of medical and radiation oncology, interventional/diagnostic radiology, gastroenterology, pathology, transplantation and basic/ translational science. The AHPBA also welcomes Allied Health Care professionals as members. Together we meet, learn, collaborate and have fun. Besides ourselves, our patients are the ultimate beneficiaries of our endeavors.

With an array of key membership benefits, it is easy to see why so many HPB medical professionals have made the decision to join this prestigious organization.

• Membership in a large professional network of your peers

• Certificate of membership

• Discount on member mailing purchases

• Research Fellowship Grants

• AHPBA News Bulletin

• AHPBA Travel Exchange Program

• Participation in future HPB trials

• Influential fellowship match programs

• Surgical guidelines

• Annual subscription to the official journal, HPB

• Reduced registration fees to national and international meetings

• And much more...

HPB: the Official IHPBA/

Join more than 950 medical professionals in North, South and Central America specializing

in the liver, pancreas and biliary system by becoming an AHPBA member today!


Join AHPBA

24

13th Annual Meeting

AHPBA Journal HPB, the official journal of the International Hepato-Pancreato-Biliary Association and its regional associations, was launched in 1999 as an international forum for scientific and social communication. Monthly issues offer readers original research, reviews, HPB images, editorials, case reports and reader correspondence connected with the various scientific and clinical interests involved in hepatic, pancreatic and biliary disease, along with the latest news from the Association. Members in good standing can access the journal online, while Active and Candidate members may also receive it by mail. HPB has been accepted for indexing in Medline. This is a great achievement for HPB and has a significant impact on the journal’s profile and discoverability. HPB aims to help its readers - surgeons, physicians, radiologists and other scientists - to develop their knowledge and practice.

AHPBA Annual traveling Fellowship AHPBA offers two annual fellowship grants to members to encourage interaction, exchange of ideas and collaboration between HPB surgeons in North and South America. The North American Fellowship is open to members residing in North America and supports travel to South America (vice versa for the South American Fellowship).

Each fellowship is allotted $5,000 and is to be used to offset the cost of travel and accommodation for the Traveling Fellow. Successful applicants are to travel for one week to an HPB center in South, Central or North America.

Annual Meeting Each year, the AHPBA holds its Annual Meeting for the presentation and discussion of the latest findings in the sciences of the liver, pancreas and biliary tract, as well as the management of conditions that affect these organs.

the Program Includes: Plenary sessions

Oral papers

Poster sessions

Keynote lectures

Update lectures

Symposia

Face-to-face debates

Trade exhibition

Video symposium

Poster sessions on unique topics

Social and athletic events

Who should attend?HPB Surgeons

Surgical Oncologists

Transplant Surgeons

Laparoscopic Surgeons

General Surgeons

Gastroenterologists

Hepatologists

Radiologists

Endoscopists

Scientists

Pathologists

Surgical trainees

Nurses involved in HPB surgery, gastroenterology, hepatology, and transplantation

AHPBA executive Offices

kim o’dell, cmP, executive director

341 north maitland avenue, suite 130

maitland, florida 32751 usa

email: [email protected]

tel.: +01 407 647-8839 • fax: +01 407 629 2502

JOIN TODAY

25

PROOF 4

OBJetIvOSEl AHPBA se incorpora como una organización sin fines de lucro y fue creada con la visión de dedicarse a aliviar el sufrimiento humano causado por trastornos HPB en todo el mundo, mediante la mejora de la educación, la formación, la innovación, la investigación y la atención al paciente.

1 Promover el entendimiento de las causas de los trastornos del hígado, el páncreas y el árbol biliar y para investigar y tratar estas enfermedades.

2 Promover el intercambio de conocimientos clínicos y científicos entre los cirujanos y miembros de disciplinas afines que trabajan en el mismo campo.

3 Estudiar los problemas relevantes que afectan al hígado, páncreas y el tracto biliar.

4 Facilitar la colaboración para la investigación sobre los factores que conducen a la enfermedad en estos órganos y métodos para prevenirlas.

5 Fomentar la amistad entre los médicos y los científicos involucrados en las disciplinas hepática, pancreática y biliar.

6 Trabajar para alcanzar los más altos estándares éticos en los campos de las actividades de la asociación.

7 Fomentar la educación y el desarrollo profesional en el campo a través de un mecanismo de apoyo financiero identificado.

Beneficios para los miembrosTe invitamos a formar parte de nuestra organización en crecimiento, mediante la membrecía a la AHPBA. La membrecía en AHPBA te conecta a una red nacional y mundial de profesionales de la medicina que se especializa en el hígado, el páncreas y el sistema biliar. La AHPBA cuenta con una membrecía diversa de más de 950 médicos, no solamente cirujanos, pero también los principales especialistas en los campos de la radioterapia y oncología médica, intervención / radiodiagnóstico, gastroenterología, patología, trasplante y ciencias básicas y translacionales. El AHPBA también abre sus puertas a otros profesionales del cuidado de la salud como miembros asociados. Juntos podemos reunirnos, aprender, colaborar y divertirnos. Además de nosotros mismos, nuestros pacientes son los beneficiarios principales de nuestros esfuerzos.

Con una amplia gama de beneficios claves al ser miembro, es fácil entender por qué muchos profesionales médicos de enfermedades HPB han tomado la decisión de unirse a esta prestigiosa organización.

• Pertenecer a una gran red de profesionales

• Certificado de membrecía

• Descuento a los miembros en compras que requieran correo

• Becas de investigación

• Boletín de Noticias de la AHPBA

• Programas de viaje/intercambio de la AHPBA

• La participación en futuros ensayos clínicos del patología HPB

• Programas de sub-especialización (fellowships)

• Guías de manejo clínicas

• Suscripción anual a la revista oficial de la AHPBA: HPB

• Reducción de cuotas de inscripción para los congresos nacionales e internacionales

• Y mucho mas….

Únete a más de 950 profesionales de la medicina del Norte, Centro y Sur América especializados en el manejo de las enfermedades del hígado, el páncreas y el sistema biliar al convertirte en un miembro AHPBA hoy!


Join AHPBA

26

13th Annual Meeting

HPB: la revista oficial de la AHPBA y la IHPBA HPB, la revista oficial de la International Hepato-Pancreato-Biliary Asociation y de sus asociaciones regionales, se inició en 1999 como un foro internacional para la comunicación científica y social. Mensualmente ofrece a los lectores temas de investigación originales, comentarios, imágenes HPB, editoriales, informes de casos y correspondencia relacionada con distintos intereses científicos y clínicos en el campo de las enfermedades hepáticas, pancreáticas y biliares, junto con las últimas noticias de la Asociación. Todos los miembros al día con la Asociación tienen acceso a la revista en línea. Asimismo, los miembros Activos y Candidatos también pueden recibir la revista por correo. HPB acaba de ser aceptado para la indexación en Medline. Este es un gran logro para HPB y tiene un impacto significativo en el perfil de la revista y su exposición. HPB tiene como objetivo ayudar a sus lectores - cirujanos, médicos, radiólogos y otros científicos - a desarrollar sus propios conocimientos y práctica.

Beca/Fellowship Anual de Intercambio/viajeLa AHPBA ofrece dos becas anuales a los miembros para fomentar la interacción, el intercambio de ideas y la colaboración entre cirujanos HPB en América del Norte y Suramérica. Las Becas de América del Norte están abiertas a los miembros que residen en América del Norte y apoya los viajes a América del Sur (y viceversa para la Comunidad de América del Sur).

Cada beca es por un valor de USD $ 5.000 y se utiliza para compensar los gastos de viaje y alojamiento de la persona becada. Los candidatos elegidos serán los afortunados y viajaran durante una semana a un centro de HPB en America del Sur, América Central o América del Norte.

reunión AnualCada año, el AHPBA celebra su reunión anual para la presentación y discusión de los últimos descubrimientos en las ciencias del hígado, páncreas y vías biliares, así como el tratamiento de las enfermedades que afectan a estos órganos.

el programa incluye:Sesión plenaria

Presentaciones orales

Sesiones de posters

Conferencias magistrales

Conferencias sobre actualización de temas

Simposios

Debates cara a cara

Simposio de videos

Sesiones de posters sobre temas únicos

Exposiciones comerciales

Eventos deportivos y Sociales

A quién va dirigido?Cirujanos HPB

Cirujanos Oncólogos

Cirujanos de Trasplantes

Cirujanos de Laparoscopia

Cirujanos Generales

Gastroenterólogos

Hepatólogos

Radiólogos

Endoscopistas

Científicos

Patólogos

Estudiantes de cirugía

Las enfermeras que participan en la cirugía HPB, gastroenterología, hepatología y trasplante

AHPBA - Oficinas ejecutivas:

kim o’dell, cmP, director ejecutivo 341 n. maitland avenue, suite 130

maitland, florida 32751 usa.

correo electrónico: [email protected]

tel:. 01 407 647-8839

fax: +01 407 629 2502

27

PROOF 4

HIBISCUS

BAYSHORE

STAR

PALM

LIL GORCE

KEY BISCAYNE

A

KEY BISCAYNE

B

FISHER A

FISHER B

BELLE

SAN MARCO

SAN MARINO

EX

EC

UT

IVE

B

OA

RD

RO

OM

RIVO ALTO

PALLADIIUM

BUSINESS CENTER

GROUP OFFICE

Lower Lobby Level

Conference Level

Mezzanine Level

hotel floor Plan


AHPBA 2013

28

13th Annual Meeting

POMPEII BALLROOM

PROMENADE ROOM

MONA LISA FOYER

MONA LISA

RECEPTION

LOBBY

RESTAURANT

PROMENADE FOYER

Lobby Level

A B

hotel floor Plan

OCEAN BALLROOM

IIA

OCEAN BALLROOM

IIB

OCEAN BALLROOM

IIC

LAPIDUS

WATSON

OCEAN BALLROOM

IA

OCEAN BALLROOM

IB

OCEAN BALLROOM

IC

Penthouse FloorOcean Tower

SUNNY ISLES BAL

HARBOUR

WATER VEIW

TERRACE

Annual Meeting

29

Advanced Energy for Laparoscopic Surgery

Introducing the Aquamantys® Endo DBS 8.7 Dissecting Bipolar Sealer for laparoscopic surgery. Cone-shaped electrodes enable blunt dissection and deliver patented Transcollation® technology, which provides hemostatic sealing of soft tissue during surgery.

www.medtronicadvancedenergy.com

AHPBABooth#1

© 2013, Medtronic, Inc. All rights reserved. Aquamantys® and Transcollation® are registered trademarks of Medtronic, Inc.SLA-13-002182 2.13

13th Annual Meeting

8:00 - 11:30 AM CoMMITTEE MEETInGS

room: Fischer a/B room: Belle executive Boardroom room: Sunny isles7:00 - 8:00 am Fellows Sub-committee Allied

Healthcare Professionals

Foundation Board

8:00 - 9:00 am HPB Program Directors Membership Research Finance9:15 - 10:15 am Education & Training CETAT Development10:30 - 11:30 am Professional

DevelopmentProgram Publications International

Relations

7:30 am hPB Ultrasound course registration & continental BreakfastLocation: Lapidus Foyer

8:00 AM - 5:00 PM HPB ulTRASounD AnD ADVAnCED TECHnoloGy CouRSE - DIDACTIC PoRTIonModerator and Course Organizer: Ellen HagopianRoom: Lapidus

8:00 - 8:05 am Welcome & introduction - Ellen Hagopian

8:05 - 8:10 am importance of Ultrasound in hPB Surgery - Ellen Hagopian

8:10 - 8:30 am US Principles & instrumentation - Beth Schrope.

8:30 - 8:55 am liver US: Normal anatomy and Pathologic Findings - Paul Hansen

8:55 - 9:25 am Pancreas US: Normal anatomy and Pathologic Findings - D. Rohan Jeyarajah

9:205 - 9:40 am refreshment Break

9:40 - 10:00 am Gallbladder & Bile duct US: Normal anatomy and Pathology - Reid Adams

10:00 - 10:20 am US Scanning Techniques: TaUS, ioUS & laP - Eren Berber

10:20 - 10:30 am introduction to hands-on Sessions - Ellen Hagopian

10:30 am -12:00 pmHands-on Session I: hBP anatomy and Technique : TaUS Using Human Models - All FacultyRoom: Key Biscayne A/B

12:00 -1:00 pm lunchOutside in the Spa Garden

1:00 pmHPB ulTRASounD AnD ADVAnCED TECHnoloGy CouRSE - DIDACTIC PoRTIon - ContinuesRoom: Lapidus

1:00 - 1:20 pm Techniques in Ultrasound Guidance : TaUS, ioUS & laP - John Martinie

1:20 - 1:40 pm Methods in Tumor ablation in hPB Surgery - Robert Martin

1:40 - 2:00 pm advanced Techniques in US imaging - Beth Schrope

2:00 - 2:15 pm Panel discussion - All faculty

2:15 - 2:30 pm refreshment Break

2:30 - 5:00 pm

Hands-on Session II Scanning Methods and Ultrasound Guidance: ioUS & laP Using Inanimate and Phantom Models - All FacultyRoom: Key Biscayne A/B

WEDNESDAY MOC icon denotes Maintenance of Certification.

AR icon denotes Audience Response.

31

PROOF 4

11:50 AM - 6:00 PM PRE ConFEREnCE SPoRTInG EVEnTS

11:50 am Golf & Fishing transportation pick up outside hotel entrance

12:30 - 6:00 pm 5th annual Golf TournamentMiami Beach Golf CourseAttendees & Exhibitors Invited

4th annual Fishing TournamentAttendees & Exhibitors Invited

2:00 - 4:00 pm ihPBa executive committee MeetingRoom: Executive Board Room

4:00 - 6:00 PM AllIED HEAlTH CARE SyMPoSIuM Moderators: Timothy Pawlik, Lindsey ManosRoom: Belle

Management of the complex hPB Patient: an allied health Perspective - Jenna Gates

developing a Pancreatic cyst Program: lessons learned - Lindsey Manos

Managing a Busy Surgery Practice: autonomy Based on Scope of Practice - Heather Jones

integration of Mid-level Providers into a Busy Surgical Practice: a Surgeon’s Practice - Douglas Evans

6:00 - 8:00 pm Speaker ready room Room: San Marco

6:30 - 8:00 pm registration desk open Ocean Tower I Foyer

7:15 - 9:00 pm executive council MeetingRoom: Lapidus/Watson


WEDNESDAY

32

13th Annual Meeting

6:30 am - 6:00 pm registration desk open Ocean Tower I Foyer

7:00 am - 6:30 pm Speaker ready room Room: San Marco

7:00 - 9:00 am executive council MeetingRoom: Lapidus/Watson

9:30 AM - 5:00 PM

MOC AR

AHPBA PoST GRADuATE CouRSE:controversies in hPB and Transplant SurgeryCourse Coordinator: William ChapmanRoom: Ocean Tower I A-Cexclusive Support Provided by ethicon endo-Surgery

9:30 - 11:00 AM lIVER/BIlIARyModerator: William R. Jarnagin

9:30 - 9:45 am alPPS vs PVe/Staged resections: Novel Surgical development or Unnecessary intervention. - David Nagorney

9:45 - 10:00 am laparoscopic vs open right hepatectomy: What are the Benefits and Who is Using This approach? - David Geller

10:00 - 10:15 am Neoadjuvant chemotherapy For colorectal Metastases to the liver - What are the data? - Bryan Clary

10:15 - 10:30 am current Management Strategies For Gallbladder cancer - Javier Lendoire

10:30 - 11:00 am Panel discussion11:00 AM - 12:30 PM TRAnSPlAnT

Moderator: William Chapman

11:00 - 11:15 am What is the role of olT for cholangiocarcinoma - Who Should We consider For this Procedure? - Julie Heimbach

11:15 - 11:30 am resection or ablation with Salvage Transplant for hcc in Setting of early Stage cirrhosis - Should We encourage This approach? - Ronnie Tung-Ping Poon

11:30 - 11:45 amWhen is Total Pancreatectomy with auto-islet Transplant indicated? - John Christein

11:45 am - 12:00 pm optimal Training in hPB Surgery: Surgical oncology, Transplant, or hPB Surgery? - Paul Greig

12:00 - 12:30 pm Panel discussion

12:30 am - 2:00 pm lunchattendees on your own at hotel restaurants New Member/Fellows/candidates/allied health

Program - By invitation onlyRoom: Lapidus-Watsonlunch Provided by the ahPBa Program supported by ethicon endo-Surgery

THURSDAY

33

PROOF 4

AHPBA PoST GRADuATE CouRSE - Continued

2:00 - 3:30 PM PAnCREASModerator: David Linehan

2:00 - 2:15 pm Standard vs laparoscopic Whipple - When and Who Should be Performing this Procedure? - Horacio Asbun

2:15 - 2:30 pm Management of locally advanced Pancreas cancer: Which Strategy is Most optimal? - Sharon Weber

2:30 - 2:45 pm is there a role for open debridement of Peripancreatic Fluid collections? - Rowan Parks

2:45 - 3:00 pm cystic disease of the Pancreas - Too Many operations for Too little Benefit? - Peter Allen

3:00 - 3:30 pm Panel discussion3:30 - 5:00 pm case Presentations

Moderator: M. B. Majella Doyle Panelists: Alan Hemming, Eduardo de Santibanes, Palepu Jagannath, Jacques Belghiti, David

Adams and Susan OrloffRadiologist Perspective: Vamsi Narra

5:15 - 6:45 pm Welcome reception in the exhibit hallRoom: Pompeii/Promenade

7:00 - 8:30 PM EDuCATIonAl DInnER SyMPoSIA Room: Ocean Tower I A-CModerator: Roderich SchwarzProgram supported by Sirtex

Y90 regional radioembolization of liver Metastases

history, Mechanism, indications, and Safety of Y90 Therapy - Joseph Espat

clinical data and comparative assessment of outcomes of Y90 Therapy. - David Kooby

Y90 Therapy in the Multidisciplinary Process including Preoperative indications - Robert Martin

8:45 - 10:15 PM THE BERnARD lAnGER FElloW’S AnD RESIDEnT’S SyMPoSIuMRoom: Ocean Tower I A-C Moderators: Paul Hansen and D. Rohan JeyarajahIntroduction to the Symposium: D. Rohan Jeyarajah , Paul Hansen Program Supported By Covidien

HBP Training: Current StatusUpdate on Manpower and Training issues - Rebecca MinterhBP centers of excellence - Rob Glasgow

Finding or Creating the Ideal JobModerators: Reid Adams, Rohan JeyarajahPanelists: David Iannitti, Scott Helton, Rebecca Minter, Carol-Anne Molten

10:30 pm Fellows/residents informal cocktail Gathering at the central Bar With leadership.


THURSDAY

34

13th Annual Meeting



6:15 - 7:30 AM PARAllEl EDuCATIonAl BREAKFAST SyMPoSIA

6:15 - 7:30 am 6:15 - 7:15 am 6:30 - 7:30 amhilar Strictures in the Setting of PSc: is There an optimal evaluation and Treatment Strategy?Room: Ocean Tower II CModerator: Steven Hanish

high intensity Focused Ultrasound for hepatic Tumor ablation: ready for Primetime?Room: Ocean Tower IA CModerator: David Sindram

optimizing the adjuvant Therapy in Patients with resectable colorectal MetastasesRoom: Ocean Tower II A/BModerator: Bryan Clary Speaker - Herbert Hurwitz

current Management of Patients with PSc; a hepatologists - Julie Heimbach

overview of the Technology and current applications. - Arik Hananel

discussion

imaging characteristics of hilar Strictures in PSc; concerning Findings Versus Progression of disease - James Costello

clinical experience, issues/limitations and Promise - Jean Francois Aubry

dominant Strictures and PSc; Neoadjuvant Protocol for cholangiocarcinoma and Transplantation. current Trends and data - Julie HeimbachSupported by: Bayer healthcare/onyx Pharmaceuticals

6:30 - 7:30 am ihPBa Ken Warren Foundation Board Meeting (Continental Breakfast)Room: Executive Board Room

7:45 - 8:20 AM PRESIDEnTIAl ADDRESS William r. Jarnagin

Giving Back - The emerging legacy of the ahPBaIntroduction of the President - William C. ChapmanRoom: Ocean Tower I A-C

William R. Jarnagin

8:20 - 8:25 am 2013 Distinguished Service Award Recipient henry a. PittRoom: Ocean Tower I A-CPresented by William R. Jarnagin, MD

Henry A. Pitt

8:25 - 8:35 am hPB certificate of completion PresentationRoom: Ocean Tower I A-CPresented by: William R. Jarnagin, Rebecca Minter

FRIDAY

35

PROOF 4

8:35 - 9:05 AM RESEARCH AWARD AnD TRAVElInG FElloWSHIP PRESEnTATIonRoom: Ocean Tower I A-C

AHPBA 2011 Research Fellowship Grant Recipient: Michelle BabickyTargeting the ron Tyronsine Kinase receptor in Pancreatic cancer2012 Traveling Fellowship Award RecipientsThomas aloia, Md, MD Anderson Cancer Center, Houston, Texas. lucas Mccormack, Md, Hospital Aleman, Buenos Aires, Argentina. Flavio rocha, Md Virginia Mason Medical Center, Seattle, Washington. Travel Fellowships supported in part by the ahPBa Foundation

9:05 -10:05 am President’s Plenary Session & Young investigator award competitionRoom: Ocean Tower I A-C

Top Four abstracts for Pancreas, liver, Biliary, Transplant

PPYI.01 DISTINCT PREDICTORS OF PRE- VERSUS POST-DISCHARGE VENOUS THROMBOEMBOLISM AFTER HEPATECTOMY: ANALYSIS OF 7,621 NSQIP PATIENTS C. D. Tzeng1, S. A. Curley1, J. N. Vauthey1, T. A. Aloia1 ; 1The University of Texas MD Anderson Cancer Center, Houston, TXdiscussant: W. Scott helton

PPYI.02 DYSPLASIA AT THE SURGICAL MARGIN PREDICTS RECURRENCE FOLLOWING RESECTION OF NON-INVASIVE IPMN T. L. Frankel1, J. LaFemina2, M. D’Angelica1, R. P. DeMatteo1, Y. Fong1, T. P. Kingham1, W. R. Jarnagin1, P. J. Allen1 ; 1Memorial Sloan-Kettering Cancer Center, New York, NY; 2University of Massachusetts Memorial Medical Center, Worcester, MAdiscussant: Mark callery

PPYI.03 VIRAL STATUS AT THE TIME OF LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: A PREDICTOR OF LONG-TERM SURVIVAL IN THE MODERN ERA R. T. Groeschl1, C. H. Pilgrim1, J. C. Hong1, T. Gamblin1 ; 1Medical College of Wisconsin, Milwaukee, WIdiscussant: reid adams

PPYI.04 DISCORDANCE BETWEEN CONVENTIONAL AND DETAILED LYMPH NODE ANALYSIS IN RESECTED BILIARY CARCINOMA AT OR ABOVE THE CYSTIC DUCT: ARE WE UNDERSTAGING PATIENTS? L. M. Ocuin1, P. Bagci2, S. B. Fisher1, S. H. Patel1, D. A. Kooby1, C. A. Staley1, N. Adsay2, S. K. Maithel1 ; 1Department of Surgery, Atlanta, GA; 2Department of Pathology, Atlanta, GAdiscussant: Jean Nicolas Vauthey

10:10 - 10:45 am coffee Break with video presentationRoom: Exhibit Hall

Video: “left hepatectomy with caudate lobectomy and extrahepatic Bile duct resection.”Eddie Abdalla, M.D

10:45 - 11:15 AM PARAllEl STATE-oF-THE-ART lECTuRES

hereditary Pancreatic cancerRoom: Ocean Tower I A-CIntroduction: Courtney ScaifeSpeaker: Steven Gallinger

MOC AR

hepatitis-related cancer ManagementRoom: Ocean Tower II A/BIntroduction: Felipe CoimbraSpeaker: Ronnie Tung-Ping Poon

MOC


FRIDAY

36

13th Annual Meeting

11:15 - 1:15 PM PARAllEl SyMPoSIASocial Media and the connected Patient - lessons for SurgeonsRoom: Ocean Tower I A-CModerator: Niraj Gusani

AR

anesthetic Technique for hPB Surgery: epidural vs. iV PcaRoom: Ocean Tower II - A/BModerator: Thomas Aloia

introduction to Social Media & the connected Patient - Niraj Gusani

argument against epidural in liver Surgery - David Kooby

Patient recruitement and engagement Through Social Media - Kiran Turaga

argument for epidural in liver Surgery - Vijaya Gottumukkala

Surgeon involvement in Patient discussion Boards / Blogs - Christopher Sonnenday

The low dose epidural Protocol - Thomas Aloia

The Future of Social Media for Surgeons - Brian McGowan

The Mdacc randomized Trial of epidural -vs- Pca in liver and Pancreas Surgery - Mark Truty

Perils and Pitfalls of Social Media Use - All Speakers Panel discussion of Guidelines - All Speakers

Panel discussion and audience Questions

11:30 am - 2:15 pm ihPBa Scientific Program committee Meeting (Lunch Provided)Room: Executive Board Room

1:15 - 2:15 PM BoXED lunCH WITH THE EXHIBIToRS WITH VIDEo PRESEnTATIonSRoom: Pompeii

Video: “laparoscopic distal Pancreatectomy: Tips, Tricks and Pitfalls.”Horacio AsbunVideos Supported by NeuWave Medical

Video: “laparoscopic liver resection: Tips, Tricks and Pitfalls.”Peter KinghamVideos Supported by NeuWave Medical

2:25 - 2:55 pm invited Presidential lecturer: leslie h. Blumgart

historical development of Specialty hPB SurgeryRoom: Ocean Tower I A-C

Leslie H. Blumgart

2:55 - 3:25 pm

MOC

leslie h. Blumgart historical lecture: The Whipple ProcedureOcean Tower 1 A-CSpeaker: Howard ReberSupported by the ahPBa Foundation

Howard Reber

FRIDAY

37

PROOF 4

3:25 - 4:55 PM PARAllEl SyMPoSIA

ahPBa-led clinical TrialsRoom: Ocean Tower I A-CModerator: Sharon Weber

MOC AR

Quality in hPB Surgery: Beyond Just the Volume of casesRoom: Ocean Tower II A/BModerator: Robert Martin and Elijah Dixon

MOCintroduction - William Jarnagin and C. Wright Pinson Predictors of readmission and Quality Parameters

in Pancreatic Surgery - Syed Ahmadidentifying ahPBa Members with Specific clinical interests: What are The options? - Timothy Pawlik

Predictors of readmission and Quality Parameters in liver Surgery - Robert Martin

What are The Most important clinical Questions? how to assess What is Most relevant to our Members. - Robert Martin

outcome Measures in hPB Surgery - how We are already Being Graded By insurance? - James M. Frazier

how to Successfully implement and Fund ahPBa-led clinical Trials Utilizing industry Partnerships - David Geller Utilizing existing cooperative Groups - Mitchell Posner discussions.

4:55 pm refreshment Break in exhibit hall / Poster Session

5:00 - 6:30 PM oRAl PoSTER I PRESEnTATIonRoom: Promenade

oral Poster i Pancreas 1Moderator: Flavio G. Rocha

OP-A1.01 DENDRITIC CELLS ADENOVIRALLY-TRANSDUCED WITH FULL-LENGTH MESOTHELIN CDNA ELICIT MESOTHELIN-SPECIFIC CYTOTOXICITY AGAINST PANCREATIC CANCER CELL LINES IN VITRO M. Miyazawa1, M. Iwahashi1, T. Ojima1, M. Tani1, M. Kawai1, S. Hirono1, K. Okada1, A. Shimizu1, Y. Kitahata1, H. Yamaue1 ; 1Second Department of Surgery, Wakayama Medical University School of Medicine, Wakayama, WAKAYAMA

OP-A1.02 AUTOTRANSPLANTATION OF POSITIVE CULTURE ISLET PRODUCT: IS DIRTY ALWAYS BAD? C. Johnson1, K. Morgan1, S. Owczarski1, H. Wang1, J. Fried1, D. Adams1 ; 1Medical University of South Carolina - Department of Surgery, Charleston, SC

OP-A1.03 COMPARED TO A CONVENTIONAL OPEN APPROACH, LAPAROSCOPIC ASSISTED PANCREATICODUODENECTOMY MAY OFFER PATIENTS BETTER PERFORMANCE STATUS AND PHYSICAL HEALTH IN THE FIRST 6 MONTHS AFTER SURGERY J. A. Graham1, A. B. Chin1, A. Rubenstein1, J. A. Nusbuam1, J. Smirniotopoulos1, R. Kayser1, L. B. Johnson1 ; 1Dept. of Surgery, Georgetown University Hospital, Washington, DC

OP-A1.05 THERE IS NO SIGNIFICANT DIFFERENCE IN PERIOPERATIVE OUTCOMES AFTER PANCREATICOGASTROSTOMY VS PANCREATICOJEJUNOSTOMY FOR RECONSTRUCTION FOLLOWING PACREATICODUDENECTOMY: A META-ANALYSIS AND SYSTEMATIC REVIEW. P. Sukharamwala1, H. Safi1, S. Parikh1, P. DeVito1, G. Bogen1, N. Parikh1, A. Ghani1 ; 1Northside Medical Center/ Northeast Ohio Medical University, Youngstown, OHIO

OP-A1.06 CONTEMPORARY DIFFERENCES IN POSTOPERATIVE OUTCOMES FOLLOWING LAPAROSCOPIC VERSUS OPEN DISTAL PANCREATECTOMY FOR PANCREATIC ADENOCARCINOMA E. P. Ceppa1, R. M. McCurdy1, J. A. Parikh1, E. M. Kilbane1, C. M. Schmidt1, N. J. Zyromski1, H. A. Pitt1, A. Nakeeb1, M. G. House1 ; 1Indiana University School of Medicine, Indianapolis, IN


FRIDAY

38

13th Annual Meeting

5:00 - 6:30 pm oral Poster 1 Presentation - Room: Promenade Continued

oral Poster i Pancreas 1Moderator: Flavio G. Rocha

OP-A1.07 THE CONTRIBUTION OF FOUNDER BRCA-PATHWAY GERMLINE MUTATIONS TO PANCREAS CANCER SUSCEPTIBILITY A. Smith1,2, A. Hall1,2, A. Volenik1,2, H. Rothenmund1,2, G. Chong3, A. Omeroglu1, P. Metrakos1, W. Foulkes1, G. Zogopoulos1,2 ; 1The McGill University Health Centre, Montreal, QC; 2The Goodman Cancer Research Centre, McGill University, Montreal, QC; 3Molecular Pathology Unit, Department of Pathology, Jewish General Hospital, Montreal, QC

OP-A1.08 METFORMIN DOES NOT INCREASE SURVIVAL FOR PATIENTS WITH DIABETES WHO UNDERGO PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA P. Toomey1, S. Ross1, A. Joseph1, A. Teta1, H. Paul1, K. Luberice1, K. Cohen1, A. Rosemurgy1 ; 1Florida Hospital Tampa, Tampa, FL

oral Poster i liver iModerator: William G. Hawkins

OP-A2.01 MATCHED COMPARISON BETWEEN ROBOTIC AND LAPAROSCOPIC MAJOR LIVER RESECTIONS IN PATIENTS WITH BENIGN AND MALIGNANT LIVER LESIONS D. C. Sukato1, S. Tohme2, S. Reddy2, J. W. Marsh2, D. Geller2, D. Bartlett4, A. Tsung2 ; 1University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Division of Hepatobiliary And Pancreatic Surgery, University of Pittsburgh Medical Center , Pittsburgh, PA; 4Division of Surgical Oncology, University of Pittsburgh Medical Center , Pittsburgh, PA

OP-A2.02 CHEMOEMBOLIZATION OUTCOMES FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS WITH COMPROMISED LIVER FUNCTION D. P. Dorn1, M. K. Bryant1, J. G. Zarzour1, J. K. Smith1, D. T. Redden1, S. Saddekni1, A. Kamel1, S. H. Gray1, D. E. Eckhoff1, D. A. DuBay1 ; 1University of Alabama At Birmingham, Birmingham, AL

OP-A2.03 MICRO-RNA PROFILING IN A MOUSE MODEL OF OBESITY-PROMOTED HCC K. J. Thompson1, N. M. Steurewald1, D. J. Neimeyer1, D. A. Iannitti1, I. H. McKillop1, D. Sindram1 ; 1Carolinas Medical Center, Charlote, NC

OP-A2.04 DIFFERENCES IN HOSPITAL CHARGES AND LENGTH OF STAYS IN PATIENTS UNDERGOING OPEN VERSUS LAPAROSCOPIC RADIOFREQUENCY ABLATION L. Watkins1, S. Varadarajuli2, R. Hawes2, S. Eubanks1, P. Arnoletti1, S. G. De La Fuente1 ; 1Florida Hospital, Division of Surgical Oncology, Orlando, FL; 2Florida Hospital, Division of Gastroenterology, Orlando, FL

OP-A2.05 LIVER RESECTION FOR NON-COLORECTAL, NON-NEUROENDOCRINE, NON-SARCOMA METASTASES: A MULTICENTER STUDY J. Hawel2, G. Martel1, K. P. Croome2, J. Rekman1, D. Quan2, F. K. Balaa1, R. Hernandez-Alejandro2 ; 1University of Ottawa, Ottawa, ON; 2Western University Canada, London, ON

OP-A2.06 BLUNT HEPATIC TRAUMA IN THE AGE OF ANGIOEMBOLIZATION: A SINGLE CENTRE EXPERIENCE K. Bertens1, K. N. Vogt1, K. P. Croome1, D. Gray1, R. Hernandez-Alejandro1 ; 1Western University Canada, London, ON

OP-A2.07 MAJOR HEPATECTOMY FOR COLORECTAL LIVER METASTASIS IN THE ELDERLY B. Howe1, K. P. Croome1, N. Sela1, R. Hernandez-Alejandro1 ; 1Western University Canada, London, ON

OP-A2.08 SAFETY AND ADVANTAGES OF COMBINED RESECTION AND MICROWAVE ABLATION IN PATIENTS WITH BILOBAR HEPATIC MALIGNANCIES P. Philips1, R. W. Farmer1, S. C. Schiffman1, K. M. McMasters1, C. R. Scoggins1, G. Callender1, M. C. Robert1 ; 1University of Louisville, Department of Surgery, Division of Surgical Oncology, Louisville, KY

OP-A2.09 FIVE AND TEN YEAR OVERALL SURVIVAL IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR PRIMARY AND METASTATIC HEPATIC MALIGNANCIES B. J. Golas1, J. W. Marsh1, J. C. Mejia1, T. C. Gamblin1, D. A. Geller1, A. Tsung1 ; 1UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA

OP-A2.10 DOES LAPAROSCOPIC LIVER RESECTION MITIGATE COMPLICATIONS J. F. Buell1, A. T. Hauch1, E. Kane1, B. Saggi1, L. Balart1, N. Shores1, E. Kandil1, J. Lee1 ; 1Tulane University, New Orleans, LA

FRIDAY

39

PROOF 4


oral Poster i Biliary and other iModerator: Jeffery Barkun

OP-A3.01 THE COST OF FUTILITY: MEASURING THE ECONOMIC IMPACT OF PERCUTANEOUS CHOLECYSTOSTOMY IN MORIBUND PATIENTS S. D. Kachare1,2, D. J. Suttle1, B. D. Carr1, N. A. Vohra1,2, T. J. Fitzgerald2, E. E. Zervos1,2 ; 1East Carolina University Brody School of Medicine, Greenville, NC; 2Vidant Medical Center, Greenville, NC

OP-A3.02 OUTCOMES OF LIVER RESECTION VERSUS OPERATIVE BILIARY DRAINAGE FOR RECURRENT PYOGENIC CHOLANGITIS IS OPERATIVE BILIARY DRAINAGE STILL RELEVANT IN THE MODERN ERA? Y. Koh1, A. Chok1, A. Chiow1, L. Lee1, S. Tan1 ; 1Changi General Hospital , Singapore, SINGAPORE

OP-A3.03 FINANCIAL IMPLICATIONS OF COMMON BILE DUCT INJURIES DURING CHOLECYSTECTOMY: ANALYSIS OF THE NATIONWIDE INPATIENT SAMPLE OVER A 10-YEAR PERIOD T. Rogers1, S. Varadarajulu2, R. Hawes2, S. Eubanks1, P. Arnoletti1, S. G. De La Fuente1 ; 1Florida Hospital, Division of Surgical Oncology, Orlando, FL; 2Florida Hospital, Division of Gastroenterology, Orlando, FL

OP-A3.04 OPTIMAL SURGICAL STRATEGY FOR ADVANCED GALLBLADDER CARCINOMA: SINGLE-CENTER ANALYSIS OF LONG-TERM SURVIVORS O. Itano1, M. Tanaka1, R. Nishiyama1, M. Tanabe1, M. Shinoda1, M. Kitago1, Y. Abe1, T. Hibi1, H. Yagi1, Y. Kitagawa1 ; 1Department of Surgery, Keio University, School of Medicine, Tokyo, TOKYO

OP-A3.06 DOCTOR, WHY DIDNT THAT GALL BLADDER COME OUT? M. Colaco1,2, A. S. Gillet1, E. Hagopian1,2, J. M. Davis1,2, J. J. Vernick1,2 ; 1Jersey Shore University Medical Center - Department of Surgery, Neptune, NEW JERSEY; 2Robert Wood Johnson Medical School, New Brunswick, NEW JERSEY

OP-A3.07 CLASSIFICATION OF THE ANATOMICAL VARIATION OF THE RIGHT POSSTERIOR SECTORAL BILE DUCT H. M. Alghamdi1,2 ; 1University Of Dammam, Alkhobar, Eastarn Provience ; 2King Fahad Hospital Of The University, Alkhobar, Eastarn Provience

OP-A3.08 BILIARY ACCESS IN PATIENTS WITH A ROUX-EN- Y GASTRIC BYPASS: WHOM AND HOW A. Khithani1,2, S. Conjeevaram1, M. Silberstein1, R. Santopietro1, L. Maffucci1, M. Rangraj1 ; 1Sound Shore Medical Center, New York Medical College, New Rochelle, NEW YORK; 2Metropolitan Hospital Center, New York Medical College, New York, NY

OP-A3.09 CHOLECYSTECTOMY IN OLDER PATIENTS: WHAT ARE THE RISKS? H. Ferdosi1, B. Wu1, T. Buddensick1, A. Sautter1, H. Shaukat1, G. Sulkowski1, D. M. Narducci1, R. Faugue1, M. Siddique1, F. Kamangar2, G. Kowdley1, S. C. Cunningham1 ; 1Saint Agnes Hospital, Baltimore, MD; 2Morgan State University, Baltimore, MD

OP-A3.10 A NOVEL PROCEDURE FOR MANAGING EXCLUDED SEGMENTAL POSTOPERATIVE BILE DUCT LEAK D. J. Lerner1, B. C. Wible1, P. Chesis4, C. Gooden2, S. Pelletier3, H. B. Randall2 ; 1University of Missouri - Kansas City Diagnostic And Interventional Radiology, Kansas City, MISSOURI; 2St. Lukes Hospital, Kansas City , MISSOURI; 3University of Michigan Health Systems, Ann Arbor, MICHIGAN; 4SSM St. Joseph Health Center , St. Charles, MISSOURI

oral Poster i TransplantModerator: Steven Hanish

OP-A4.01 PORTAL VEIN THROMBOSIS - HOW MUCH IS TOO MUCH WHEN IT COMES TO COST-EFFECTIVE LIVER TRANSPLANTATION? L. Dageford1, D. E. Moore1 ; 1Vanderbilt University Medical Center, Nashville, TN

OP-A4.02 PREDICTORS OF LENGTH OF ICU STAY AND MORTALITY AFTER LIVER TRANSPALNT S. Dumitra1, P. Chaudhury1, J. S. Barkun1, S. Alabbad1, G. Zogopoulos1, P. P. Metrakos1, S. Paraskevas1, M. Hassanain1, J. I. Tchervenkov1 ; 1McGill University Health Center- Multiorgan Tranpslantation Program, Montreal, QC - QUEBEC


FRIDAY

40

13th Annual Meeting


oral Poster i Transplant - Continued

OP-A4.03 CLOSER PROXIMITY TO THE TRANSPLANT CENTER IS ASSOCIATED WITH BETTER PHYSICAL HEALTH-RELATED QUALITY OF LIFE AFTER LIVER TRANSPLANTATION L. D. Redhage1, K. Harms1, D. E. Moore1, C. W. Pinson1, I. D. Feurer1,2 ; 1Vanderbilt University Transplant Center, Nashville, TN; 2Vanderbilt University Medical Center, Nashville, TN

OP-A4.04 PREDICTORS OF OUTCOMES IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN THE MELD ERA A. Mathur2, A. M. Makris3, J. Arrobas4, K. Bruner4, A. Imperatore4, M. Christian4, E. S. Franco1, N. Kemmer1, G. W. Neff1, A. E. Alsina1 ; 1Tampa General Medical Group, Tampa, FL; 2Department of Surgery, University of South Florida, Morsani College of Medicine, Tampa, FL; 3College of Public Health, University of South Florida, Tampa, FL; 4Office of Clinical Research, Tampa General Hospital, Tampa, FL

OP-A4.05 INDICATIONS AND OUTCOMES OF PANCREAS SURGERY AFTER LIVER TRANSPLANTATION J. C. Mejia1, J. W. Marsh1, J. Steel1, B. J. Golas1, A. Humar2, H. Zeh3, D. A. Geller1, A. Tsung1 ; 1Division of Hepatobiliary And Pancreatic Surgery, Pittsburgh, PA; 2Thomas E. Starzl Transplantation Institute, Pittsburgh, PA; 3UPMC Cancer Pavilion , Pittsburgh, PA

OP-A4.07 RE-RECURRENT NON-ALCOHOLIC STEATOHEPATITIS AFTER RE-DO LIVER TRANSPLANTATION V. Leow1, V. G. Agopian2, C. R. Lassman3, R. W. Busuttil4, D. G. Farmer5 ; 1Dumont-UCLA Multivisceral Transplant Center, David Geffen School of Medicine, LA, CA; 2Dumont-UCLA Multivisceral Transplant Center, David Geffen School of Medicine, LA, CA; 3UCLA Department of Pathology And Laboratory Medicine, David Geffen School of Medicine, LA, CA; 4Dumont-UCLA Multivisceral Transplant Center, David Geffen School of Medicine, LA, CA; 5Dumont-UCLA Multivisceral Transplant Center, David Geffen School of Medicine, LA, CA

oral Poster i liver iiModerator: Allan Tsung

OP-A5.01 ANATOMICAL HEPATECTOMY USING ICG NAVIGATION SYSTEM S. Hayami1, M. Ueno1, S. Yamaguchi1, M. Kawai1, M. Tani1, H. Yamaue1 ; 1Wakayama Medical University Second Department of Surgery, Wakayama, WAKAYAMA

OP-A5.03 PKI-587 AND SORAFENIB ADDITIVELY INHIBIT PROLIFERATION OF LIVER CANCER STEM CELLS AND HCC CELL LINES R. Gedaly1, P. Angulo2, J. Hundley1, M. F. Daily1, M. Shah1, R. Galuppo1, C. Chen1, B. M. Evers3 ; 1Department of Surgery, University of Kentucky, Lexington, KY; 2Department of Internal Medicine, University of Kentucky, Lexington, KY; 3Markey Cancer Center, University of Kentucky, Lexington, KY

OP-A5.04 PANCREAS AND LIVER SURGERY IN JEHOVAHS WITNESSES: FEASIBLE AND SAFE I. T. Konstantinidis1, P. J. Allen1, M. I. DAngelica1, R. P. DeMatteo1, Y. Fong1, T. Kingham1, W. R. Jarnagin1 ; 1Memorial Sloan-Kettering Cancer Center HepatoPancreatoBiliary Surgery Department, New York, NY

OP-A5.05 TARGETING BETA-CATENIN SIGNALING PATHWAY IN LIVER CANCER STEM CELLS AND IN HCC CELL LINES WITH FH 535 R. Gedaly1, P. Angulo2, J. Hundley1, M. F. Daily1, M. Shah1, R. Galuppo1, C. Chen1, X. Zhang3, K. A. Esser3, B. M. Evers4 ; 1Department of Surgery, University of Kentucky, Lexington, KY; 2Department of Internal Medicine, University of Kentucky, Lexington, KY; 3Department of Physiology, University of Kentucky, Lexington, KY; 4Markey Cancer Center, University of Kentucky, Lexington, KY

OP-A5.06 PREDICTORS OF EARLY POST-OPERATIVE MORTALITY FOLLOWING RIGHT EXTENDED HEPATECTOMY A. Zhuruk1, K. P. Croome1, R. Leeper1, N. Sela 1, R. Hernadez-Alejandro1 ; 1Western University Canada, London, ON

OP-A5.07 PROGNOSTIC FACTORS AFTER HEPATECTOMY FOR INTRAHEPATIC CHOLANGIOCARCINOMA: RELEVANCE OF LYMPH NODE DISSECTION T. Hibi1, O. Itano1, T. Fujimura1, M. Shinoda1, M. Kitago1, H. Yagi1, Y. Abe1, M. Tanabe1, Y. Kitagawa1 ; 1Department of Surgery, Keio University School of Medicine, Shinjuku-ku, TOKYO

FRIDAY

41

PROOF 4


oral Poster i liver ii - Continued

OP-A5.09 CLAVIEN COMPLICATIONS OF LAPAROSCOPIC VS. OPEN LIVER RESECTION: A RETROSPECTIVE REVIEW E. Kane1, A. Hauch1, J. F. Buell1, J. Lee1, B. Saggi1, L. Balart1, N. Shores1, E. Kandil1 ; 1Tulane University , New Orleans, LA

OP-A5.10 TWO STAGED HEPATECTOMY FOR “UNRESECTABLE” COLORECTAL LIVER METASTASES: THE USE OF THE ALPPS PROCEDURE TO INDUCE RAPID HYPERTROPHY IN SCENARIOS WHERE TRADITIONAL RESECTION STRATEGIES WERE DEEMED TO BE SUBOPTIMAL K. P. Croome1, L. VanHouwelingen1, R. Hernandez-Alejandro1 ; 1Western University Canada, London, ON

oral Poster i Pancreas iiModerator: Charles R. Scoggins

OP-A6.01 HIGH RATES OF PATHOLOGIC COMPLETE OR NEAR COMPLETE RESPONSE FOLLOWING NEOADJUVANT CHEMOTHERAPY AND STEREOTACTIC BODY RADIATION THERAPY FOR BORDERLINE RESECTABLE PANCREATIC CANCER M. Chuong1, E. Mellon1, S. Hoffe1, R. Shridhar1, P. Hodul1, G. Springett1, C. Harris1, S. Vignesh1, J. Klapman1, M. Hamilton1, T. Valone1, N. Roehnelt1, H. Widell1, T. Hutchinson1, M. Malafa1, R. Karl1, N. Figura2, B. Centeno1 ; 1H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; 2University of South Florida College of Medicine, Tampa, FL

OP-A6.02 IPMN TYPE BUT NOT GRADE OF DYSPLASIA IS ASSOCIATED WITH SMOKING K. M. Shaffer1, M. R. Barron1, E. C. Sturm1, C. Schmidt1, M. A. Al-Haddad2, J. M. Dewitt2, J. A. Waters1, C. M. Schmidt1 ; 1Indiana University School of Medicine Department of Surgery, Indianapolis, IN; 2Indiana University School of Medicine Department of Gastroenterology, Indianapolis, IN

OP-A6.03 OUTCOME DATA FROM MUTATIONAL PROFILING OF PANCREATIC CYST FLUIDS M. J. Lybik1, D. B. Mallat2, A. Lybik1, B. Corcoran3, E. Ellsworth3, S. Jackson3, A. Terry3, S. D. Finkelstein3,4 ; 1Northside Gastroenterology Endoscopy Center, Indianapolis, IN; 2Premier Gastroenterology of Texas, Dallas, TX; 3RedPath Integrated Pathology, Pittsburgh, PA; 4Department of Pathology, Drexel University, Philadelphia, PA

OP-A6.04 STUDY OF TUMOR REGRESSION RATE IN RESECTED PANCREAS ADENOCARCINOMA AFER NEOADYUVANT TREATMENT WITH GEMCITABINA AND NAB PLACLITAXEL. PREDICTIVE VALUE OF ELASTOGRAPHY H. Duran1, E. Vicente1, Y. Quijano1, B. Ielpo1, E. Diaz1, I. Fabra1, R. Puga1, C. Oliva1, R. Caruso1, V. Ferri1, J. Plaza1, C. Corbacho1, A. Cubillo1, C. Rubio1, V. Grando1, S. Olivares1 ; 1Sanchinarro University Hospital, Madrid, MADRID

OP-A6.05 ROBOTIC ASSISTED SURGERY FOR PANCREATIC NEUROENDOCRINE TUMORS M. E. Hogg1, M. Daoaudi1, B. A. Boone1, H. M. Choudry1, K. K. Lee1, W. Marsh1, J. F. Pingpank1, M. T. Stang1, A. Tsung1, A. J. Moser2, D. L. Bartlett1, H. J. Zeh1, A. H. Zureikat1 ; 1University of Pittsburgh Medical Center, Pittsburgh, PA; 2Beth Isreal Deaconess Medical Center - Harvard Medical School, Boston, MA

OP-A6.06 NEW SURGICAL STRATEGY FOR PATIENTS WITH PANCREATIC BODY/TAIL CARCINOMA -THE IMPACT OF DISTAL PANCREATECTOMY WITH EN-BLOC CELIAC AXIS RESECTION- H. Yamaue1, M. Kawai1, K. Okada1, M. Tani1, S. Hirono1, M. Miyazawa1, A. Shimizu1, Y. Kitahata1, H. Yamaue1 ; 1Second Department of Surgery, Wakayama Medical University, Wakayama, WAKAYAMA

OP-A6.07 LAPAROSCOPIC TRANSGASTRIC DEBRIDEMENT OF WALLED-OFF PANCREATIC NECROSIS: A NEW THERAPEUTIC OPTION FOR PATIENTS WITH NECROTIZING PANCREATITIS. S. Kulkarni1, L. Matsuoka1, A. Bogart1, R. Selby1, D. Parekh1 ; 1Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA

OP-A6.08 THE EVALUATION AND STRATIFICATION OF PERIOPERATIVE RISK FACTORS FOR DELAYED GASTRIC EMPTYING AFTER PANCREATICODUODENECTOMY IN ORDER TO IDENTIFY SELECTION CRITERIA FOR PROPHYLACTIC SURGICAL ENTERAL ACCESS M. B. Bailey1, D. Davenport1, P. C. McGrath1, S. McKenzie1 ; 1University of Kentucky, Lexington, KY


FRIDAY

42

13th Annual Meeting


oral Poster i Pancreas iiiModerator: Alice Wei

OP-A7.01 PANCREATODUODENECTOMY IN AMERICA: DO PRACTICE PATTERNS VARY? S. C. Pitt1, T. S. Riall2, M. E. Kilbane3, B. L. Hall1, H. A. Pitt3 ; 1Washington University In St. Louis, St. Louis, MO; 2University of Texas Medical Branch, Galveston, TX; 3Indiana University, Indianapolis, IN

OP-A7.02 OPERATIVE MANAGEMENT OF NECROTIZING PANCREATITIS AT A SINGLE INSTITUTION K. J. Lafaro1, G. Tran1, D. Fernando2, D. J. Vajgrt2, L. K. Findeiss2, A. N. Demirjian1, D. K. Imagawa1 ; 1University of California, Irvine Medical Center, Division of Hepatobiliary And Pancreas Surgery, Orange, CA; 2University of California, Irvine Medical Center, Division of Interventional Radiology, Orange, CA

OP-A7.03 SAFETY AND EFFICACY OF LIGASURE USAGE IN PANCREATICODUODENECTOMIES: A RETROSPECTIVE EXPERIENCE O. S. Eng1, J. Goswami2, D. Moore3, C. Chen3, C. Gannon4, D. August5, D. R. Carpizo5 ; 1Division of General Surgery, New Brunswick, NJ; 2Department of Surgery, Pittsburgh, PA; 3Department of Biostatistics, New Brunswick, NJ; 4Advanced Surgical Associates of New Jersey, Pennington, NJ; 5Division of Surgical Oncology, New Brunswick, NJ

OP-A7.04 PATIENTS WITHOUT INSULIN-DEPENDENT DIABETES OR HYPERLIPIDEMIA HAVE INCREASED SURVIVAL AFTER PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA P. Toomey1, S. Ross1, A. Joseph1, A. Teta1, K. Luberice1, K. Cohen1, A. Rosemurgy1 ; 1Southeastern Center For Digestive Disorders And Pancreatic Cancer, Tampa, FL

OP-A7.05 EARLY PREDICTOR OF OUTCOME AFTER PANCREATICODUODENECTOMY WITH POSTOPERATIVE PANCREATIC FISTULA RISK CALCULATOR J. A. Graham 1, R. Kayser1, J. Smirniotopoulos1, J. A. Nusbaum1, L. B. Johnson1 ; 1Department of Surgery, Washington, DC

OP-A7.06 NOT ALL NODES ARE THE SAME: NODAL STATIONS VARIABILITY IN PANCREATICODUODENECTOMY (PD) AND ROLE IN DECISION MAKING H. Osman1, A. Thomas1, D. R. Jeyarajah1 ; 1Methodist Dallas Medical Center, Dallas, TEXAS

OP-A7.07 BODY MASS INDEX (BMI): DOES IT MAKE A DIFFERENCE IN PANCREATICODUODENECTOMY OUTCOME? H. Osman1, A. Thomas1, D. R. Jeyarajah1 ; 1Methodist Dallas Medical Center, Dallas, TEXAS

OP-A7.08 NONTHERAPEUTIC LAPAROTOMY INCIDENCE IS NOT AFFECTED BY VOLUME OF PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA P. Toomey1, S. Ross1, C. Childs2, K. Patel1, K. Luberice1, A. Rosemurgy1 ; 1Southeastern Center For Digestive Disorder And Pancreatic Cancer, Florida Hospital Tampa, Tampa, FL; 2Morsani College of Medicine, Tampa, FL

6:30 - 7:15 pm cocktail reception in the exhibit hall with Video Presentation.Room: PompeiiVideo: “Use of Transplant Techniques for complex hepatic resection.”Will Chapman, M.D.

7:15 -10:30 pm congress BanquetWith live entertainmentOutside in the Ocean Garden

FRIDAY

43

Y-90 microspheres with RCT data and full FDA approval for mCRC in the liver.

* SIR-Spheres microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) using FUDR (Floxuridine).

1. Gray et al. Ann Oncol 2001;12:1711–20 2. van Hazel et al. J Surg Oncol 2004;88:78–85 3. Hendlisz et al. J Clin Oncol 2010;28:3687–94 SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.

© 2012 Sirtex Medical Inc. 428-U-1111

www.sirtex.com | www.facebook.com/SIRSpheresmicrospheres | 888-4-SIRTEX

Download our new iPad App for comprehensive information about Selective Internal Radiation Therapy (SIRT)

Know

You have the target. We have the weapon.

The ONLY

SIR-Spheres® microspheres are the ONLY fully FDA-approved Y-90 microspheres for the treatment of metastatic colorectal cancer (mCRC) in the liver*. The only Y-90 microspheres backed by randomized controlled trial (RCT) data, SIR-Spheres microspheres can be used alone or in combination with chemotherapy, signifi cantly extending time to progression, and improving overall survival.1,2,3

SIRTEX_5_AHPBAad.indd 1 1/17/13 9:56 AM

13th Annual Meeting

6:30 - 8:00 AM PARAllEl EVEnTS

6:45 - 7:45 am Educational Breakfast Symposia Room: Ocean Tower II C

Management of Mucinous Pancreatic neoplasmsModerator: Christopher Wolfgang

6:45 - 7:45 am Tricks of the Trade: Technical Pearls of your CraftRoom: Ocean Tower II A/BModerators: Rowan ParksChristopher Christophi

6:30 - 8:00 am Breakfast with the Exhibitors with Video PresentationVideo: “Minimally invasive to maximally invasive liver surgery - from robotics to vascular reconstruction.”Alan Hemming

Management of iPMN/McN and overview of the international consensus Guidelines - Carlos Fernandez del Castillo

Genetics and Biology of iPMN/McN (with emphasis on how this potentially alters management) - Max Schmidt

controversies in Management of iPMN/McN - Peter Allen • Total vs. Partial Pancreatectomy for Main Duct iPMN

• What constitutes Solid Component/Mural Nodule?

• Size as an indication for resection

Panel discussion/open for questions

Tricks of The Trade Room: Ocean Tower II A/BModerators: Rowan Parks and Christopher Christophi

ToT.01 ALPPS: TIPS AND TRICKS F. Alvarez1, V. Ardiles1, R. Sanchez Claria1, J. Pekolj1, E. De Santibañsup>1 ; 1HPB Surgery And Liver Transplant Unit. Hospital Italiano De Buenos Aires, Buenos Aires, Buenos Aires

ToT.02 HEPATIC OUTFLOW MODULATION TO TARGET LIVER REGENERATION S. Balzan1,2,3, V. G. Gava1,3, M. A. Magalhaes2,3, M. L. Dotto1,2, S. Balzan1,2,3 ; 1University of Santa Cruz Do Sul - UNISC, Santa Cruz Do Sul, RS; 2Ana Nery Hospital / Institute of Oncology Saint Gallen, Santa Cruz Do Sul, RS; 3Moinhos De Vento Hospital, Porto Alegre, RS

ToT.03 TRANSECTION OF THE NECK OF THE PANCREAS: PANCREATIC DUCT ISOLATION J. A. Stauffer1, M. G. Mesleh1, H. J. Asbun1 ; 1Mayo Clinic, Jacksonville, FL

ToT.04 MEDIAL OPEN TRANSVERSUS ABDOMINIS PLANE (MOTAP) CATHETER ANALGESIA: A SIMPLE, SAFE, EFFECTIVE TECHNIQUE FOLLOWING OPEN LIVER RESECTION R. Behman1, P. McHardy1, J. Sawyer1, J. Lam-McCulloch1, C. Law1, N. Coburn1, S. Hanna1, P. Karanicolas1, . ; 1Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario

ToT.05 TECHNIQUES FOR ENUCLEATION OF PANCREATIC MASSES N. N. Nissen1, V. G. Menon1, V. C. Puri1, A. Annamalai1 ; 1Cedars-Sinai Medical Center, Los Angeles, CA

ToT.06 HIGH-RISK CENTRAL PANCREATECTOMY MANAGED WITH DUAL PANCREATIC-ENTERIC ANASTOMOSIS N. N. Nissen1, V. G. Menon1 ; 1Cedars-Sinai Medical Center, Los Angeles, CA

7:00 - 8:00 am Joint ihPBa and ahPBa executive committee Meeting (Continental Breakfast)Room: Executive Board Room

SATURDAY

45

PROOF 4



8:00 - 10:00 AM oRAl ABSTRACTS - PARAllEl SESSIonS

liver iRoom: Ocean Tower II A/BModerators: Natalie Coburn & Flavio Rocha

Pancreas iRoom: Ocean Tower II CModerators: Shailesh Shrikhande & Michele Molinari

Transplant/BiliaryRoom: Ocean Tower I A-CModerators Nestor Gomez & Satish Nadig

long oral i-a - liver iRoom: Ocean Tower II A/B

O1-A.01 RIGHT POSTERIOR SECTORECTOMY IS PREFERRED OVER RIGHT HEPATECTOMY FOR POSTERIOR LESIONS: A DUAL-INSTITUTION STUDY S. B. Fisher1, P. J. Kneuertz2, R. M. Dodson2, S. H. Patel1, C. A. Staley1, S. K. Maithel1, T. M. Pawlik2, D. A. Kooby1 ; 1The Winship Cancer Institute, Emory University, Atlanta, GA; 2The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MDdiscussant: Srinevas reddy

O1-A.02 HEMOSTATIC EFFICACY OF LATEST GENERATION FIBRIN SEALANT AFTER HEPATIC RESECTION; A RANDOMIZED CONTROLLED CLINICAL STUDY H. Bektas1, S. Nadalin2, J. Schmidt3, I. Szabo4, B. Ploder4, M. Sharkhawy4 ; 1Medizinische Hochschule Hannover, Klinik F. Allgemein-, Viszeral- U. Transplantationschirurgie, Hannover, NIEDERSACHSEN; 2Eberhard Karls Univ. Tuebingen, Klinik F. Allgemein-, Viszeral- U. Transplantationschirurg., Tuebingen, BADEN-WUERTTEMBERG; 3Hirslanden Clinics Zurich, Zurich, ZURICH; 4Baxter Innovations GmbH, Vienna, VIENNAdiscussant: Sharona B. ross

O1-A.03 LIVER RESECTION AFTER DOWNSTAGING CHEMOTHERAPY IN PATIENTS WITH INITIALLY UNRESECTABLE COLORECTAL LIVER METASTASES. N. A. Devaud1, Z. S. Kanji1, N. Dhani2, R. Grant1, H. Shoushtari 1, P. Serrano1, S. Nanji1, P. D. Greig1, I. D. McGilvray1, C. A. Moulton1, A. Wei1, S. Cleary1, S. Gallinger1 ; 1Toronto General Hospital, University Health Network (UHN), Toronto, ONTARIO; 2Princess Margaret Hospital, University Health Network (UHN), Toronto, ONTARIOdiscussant: Jennifer lafemina

O1-A.04 HEPATIC HEMANGIOMAS: HOW MUCH GROWTH IS NORMAL OVER LONG-TERM FOLLOW-UP? H. Y. Hasan1, J. L. Hinshaw3, E. J. Borman3, A. Gegios2, E. R. Winslow2 ; 1Medical College of Wisconsin, Milwaukee, WI; 2University of Wisconsin, Madison, WI; 3University of Wisconsin, Madison, WIdiscussant: Thomas e. clancy

O1-A.05 ENUCLEATION OF HEPATIC NEUROENDOCRINE TUMOR METASTASES N. N. Nissen1, V. G. Menon1 ; 1Cedars-Sinai Medical Center, Los Angeles, CAdiscussant: Michael house

O1-A.06 IMPACT OF SARCOPENIA ON OUTCOMES FOLLOWING INTRA-ARTERIAL THERAPY OF HEPATIC MALIGNANCIES R. Dodson1, A. Firoozmand1, O. Hyder1, V. Tahcer1, D. Cosgrove1, N. Bhagat1, I. Kamel1, J. Geschwind1, T. M. Pawlik1 ; 1Johns Hopkins Hopsital, Baltimore, MDdiscussant: cllifford cho

O1-A.07 COMPARISON OF MICROWAVE ABLATION AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREAMTENT OF HEPATOCELLULAR CARCINOMA L. A. Shirley1, J. C. Henry1, L. Malhotra1, P. M. Bloomston1, C. R. Schmidt1 ; 1The Ohio State University Medical Center, Columbus, OHdiscussant: ajay V. Maker

O1-A.08 POST-TREATMENT SURVEILLANCE OF PATIENTS WITH HEPATOCELLULAR CARCINOMA: DOES INTENSITY OF FOLLOW-UP IMAGING IMPACT OUTCOMES O. Hyder1, H. Nathan1, D. Cosgrove1, K. Hirose1, C. Wolfgang1, J. Geschwind1, M. Choti1, J. Herman1, I. Kamel1, T. Pawlik1 ; 1Johns Hopkins Hospital, Baltimore, MDdiscussant: conrad h. Simpfendorfer


SATURDAY

46

13th Annual Meeting

8:00 - 10:00 am oral abstracts - Parallel Sessions Continued

long oral i-B - Pancreas iRoom: Room: Ocean Tower II C

O1-B.01 PANCREATIC NEUROENDOCRINE TUMORS: HYPOENHANCEMENT ON ARTERIAL PHASE COMPUTED TOMOGRAPHY PREDICTS BIOLOGIC AGGRESSIVENESS D. J. Worhunsky1, J. A. Norton1, B. C. Visser1, P. D. Poullos1, G. A. Poultsides1 ; 1Stanford University Medical Center, Stanford, CAdiscussant: Yun Shin chun

O1-B.02 DOES TRAVEL DISTANCE INFLUENCE LENGTH OF STAY IN ELECTIVE PANCREATIC SURGERY? K. L. Jackson1, R. E. Glasgow1, M. C. Mone1, S. J. Mulvihill1, X. Sheng2, C. L. Scaife1 ; 1Department of Surgery, Salt Lake City, UT; 2Department of Pediatrics, Salt Lake City, UTdiscussant: david Kooby

O1-B.03 SYMPTOMATIC WALLED-OFF PANCREATIC NECROSIS (WOPN): IS THERE STILL A ROLE FOR THE SURGEON? S. Damle1, A. Alseidi1, S. I. Gan2, R. Kozarek2, A. Ross2, S. Irani2, R. Crane3, M. Fotoohi3, E. Hauptmann3, M. Gluck2, W. S. Helton1, F. G. Rocha1 ; 1HPB Service, Department of Surgery, Seattle, WA; 2Gastroenterology Service, Department of Medicine, Seattle, WA; 3Interventional Radiology Service, Deparment of Radiology, Seattle, WAdiscussant: Ketan Sheth

O1-B.04 PREDICTING THE RISKS OF VENOUS THROMBOEMBOLISM VERSUS POST-PANCREATECTOMY HEMORRHAGE: ANALYSIS OF 13,771 NSQIP PATIENTS C. D. Tzeng1, M. H. Katz1, J. E. Lee1, J. B. Fleming1, P. W. Pisters1, J. N. Vauthey1, T. A. Aloia1 ; 1The University of Texas MD Anderson Cancer Center, Houston, TXdiscussant: Miguel Mercado

O1-B.05 LAPAROSCOPIC CYSTOGASTROSTOMY A. Kamyab1, M. J. Jacobs1 ; 1Providence Hospital And Medical Centers, Southfield, MI

O1-B.06 DOES NEOADJUVANT RADIATION THERAPY FOR PANCREATIC CANCER INCREASE POST-OPERATIVE COMPLICATIONS AFTER PANCREATICODUODENECTOMY? ANALYSIS OF AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (ACS NSQIP) S. W. Cho1, W. C. Johnston1, M. A. Cassera1, P. H. Newell1, C. W. Hammill1, R. F. Wolf1, P. D. Hansen1 ; 1Providence Portland Medical Center, Portland, ORdiscussant: Becke White

O1-B.07 FAILURE TO FOLLOW EVIDENCE-BASED, BEST-PRACTICE GUIDELINES IN THE TREATMENT OF SEVERE PANCREATITIS. A. Vlada1, B. Schmit1, J. Trevino1, K. Behrns1, S. J. Hughes1 ; 1University of Florida, Gainesville, FLdiscussant: charles M. Vollmer, Jr.

O1-B.08 IMPROVED MORTALITY IN ACUTE PANCREATITIS ASSOCIATED WITH EARLY PANCREATIC DEBRIDEMENT - ANALYSIS OF 3,617 PATIENTS UTILIZING THE NATIONWIDE INPATIENT SAMPLE B. A. Wormer1, R. Z. Swan1, K. B. Williams1, J. F. Bradley1, A. L. Walters1, J. B. Martinie1, B. T. Heniford1 ; 1Carolinas Medical Center, Charlotte, NCdiscussant: eugene ceppa

long oral i-c - Transplant/BiliaryRoom: Ocean Tower I A-C

O1-C.01 ENDOSCOPIC ULTRASOUND IS A SAFE AND EFFECTIVE ALTERNATIVE TO PORTAL NODE SAMPLING IN PATIENTS ENROLLED THE CHOLANGIOCARCINOMA TRANSPLANT PROTOCOL S. I. Hanish1, E. Marchan3, F. Willingham2, J. Landry3, J. Kauh4, J. Magliocca1, A. Adams1, . , J. Spivey2, S. Knechtle1 ; 1Emory University Department of Surgery, Division of Liver Transplantation, Atlanta, GEORGIA; 2Emory University Department of Gastroenterology, Atlanta, GEORGIA; 3Emory University Department of Radiation Oncology, Atlanta, GEORGIA; 4Emory University Department of Medical Oncology, Atlanta, GEORGIAdiscussant: chad Ball

SATURDAY

47

PROOF 4

8:00 - 10:00 am oral abstracts - Parallel Sessions Continued

long oral i-c - Transplant/Biliary - Room: Room: Ocean Tower I A-C Continued

O1-C.02 ISLET AUTOTRANSPLANTATION AFTER PANCREATECTOMY IN DIABETICS: IS IT WORTH IT? A. Patel1, K. Morgan1 ; 1Medical University of South Carolina, Charleston, SCdiscussant: Milan Kinkhabwala

O1-C.03 HEPATIC ISCHEMIC PRECONDITIONING INCREASES PORTAL BLOOD FLOW IN EXPERIMENTAL LIVER ISCHEMIA/ REPERFUSION INJURY IN RATS E. Ramos Figueira1,2, J. A. Rocha Filho1,3, M. Nakatani4, E. R. Tatebe5, V. Oliveira Andre6, M. F. Souza Buto5, F. F. Galvao1,7, E. Chaib1,7, C. Lanchotte1, I. Cecconello2, L. C. D’ Albuquerque1,7 ; 1Laboratory of Medical Investigations - LIM37, University of SaoPaulo School of Medicine, Sao Paulo, SP; 2Discipline of Digestive Surgery, Department of Gastroenterology, HC-FMUSP, Sao Paulo, SP; 3Discipline of Anestesiology, University of Sao Paulo School of Medicine, Sao Paulo, SP; 4Scientific Initiation FAPESP 2011/09434-8, University of Sao Paulo School of Medicine, Sao Paulo, SAO PAULO; 5Scientific Initiation, University of Sao Paulo School of Medicine, Sao Paulo, SP; 6Scientific Initiation FAPESP 2011/08759-0,University of Sao Paulo School of Medicine, Sao Paulo, SP; 7Discipline of Liver And Gastrointestinal Transplant, Department of Gastroenterology, HC-FMUSP, Sao Paulo, SPdiscussant: david Sindram

O1-C.04 PRIMARY CHOLEDOCHORRHAPHY IS ASSOCIATED WITH REDUCED COMPLICATIONS COMPARED TO T-TUBE DRAINAGE AFTER CHOLEDOCHOTOMY : A META-ANALYSIS AND A SYSTEMATIC REVIEW P. B. Sukharamwala1, S. Parikh1, H. Safi1, N. Parikh1, J. Smith1, A. Ghani1, P. DeVito1 ; 1Northside Medical Center/ Northeast Ohio Medical University, Youngstown, OHIOdiscussant: Purvi Parikh

O1-C.06 ADULT CHOLEDOCHAL CYST: A SINGLE CENTRE EXPERIENCE IN MANAGEMENT F. Vyas1, P. Joseph1, R. Sanghi1, V. Sitaram1 ; 1Christian Medical College, Vellore, TAMIL NADUdiscussant: atilla Nakeeb

O1-C.07 SURVIVAL AND CANCER RECURRENCE IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN THE LAST DECADE: IS THERE PROGRESS? A. Mathur2, A. M. Makris3, J. Arrobas4, K. Bruner4, A. Imperatore4, M. Christian4, G. Neff1, E. Franco1,2, N. Kemmer1, A. E. Alsina1,2 ; 1Tampa General Medical Group, Tampa, FL; 2Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL; 3College of Public Health, University of South Florida, Tampa, FL; 4Office of Clinical Research, Tampa General Hospital, Tampa, FLdiscussant: christopher J. Sonnenday

O1-C.08 SURGICAL PORTO-SYSTEMIC SHUNTS IN THE ERA OF TIPS AND LIVER TRANSPLANTATION ARE STILL RELEVANT I. Gur1, B. Diggs1, S. L. Orloff1 ; 1OHSU, Portland, OREGONdiscussant: Paul Greig

10:00 - 10:45 AM PARAllEl uPDATE lECTuRES

liver resection For colorectal Metastases with extrahepatic disease - review of the dataRoom: Ocean Tower I A-CIntroduction: Allan TsungPresenter: Jacques BelghitiOpinion: Javier Lendoire

MOC AR

Management of choledochal cysts in the Modern imaging eraRoom: Ocean Tower II A/B Introduction: Attila Nakeeb Presenter: Xabier de Aretxabala Opinion: David Nagorney

MOC

10:45 - 11:15 am Break in the exhibit hall with Video Presentation

Video: “hepatic resection with hepatic vein reconstruction: how and when?” Ian McGilvray, M.D.


SATURDAY

48

13th Annual Meeting

11:15 - 12:00 PM PARAllEl DEBATES

debate 1: enucleation is recommended For Benign Pancreatic lesionsRoom: Ocean Tower II A/BModerator: Carlos Chan

MOC

debate 2: all complex hepatic cysts Should Be resectedRoom: Ocean Tower 1 A-CModerator: Natalie Coburn

MOC AR

Pro: Max Schmidt con: Jennifer Tseng Pro: Juan Pekolj con: reid adams

12:00 - 1:00 PM SEQuEnTIAl STATE-oF-THE-ART lECTuRES

optimal Techniques For Kidney and liver Preservation during cadaveric TransplantRoom: Ocean Tower I A-CIntroduction: Milan Kinkhabwala Presenter: Oscar Imventarza

MOC AR

Transplantation for NaShRoom: Ocean Tower I A-CIntroduction: Christopher Sonnenday Presenter: Luiz Carneiro D’Albuquerque

MOC AR

1:00 - 2:00 PM PARAllEl EDuCATIonAl lunCH SyMPoSIA

hepatic Parenchymal Transection Techniques: is a Tonsil clamp Sufficient? Where do contemporary energy Platforms Fit?Room: Ocean Tower I A-CModerator: Charles ScogginsProgram Supported by: Medtronic, inc.

MOC

laparoscopic Surgical approaches and Use of advanced energy for Pancreas and StomachRoom: Ocean Tower II A/BSpeaker: Kevin WatkinsProgram Supported by: ethicon-endo Surgery

Dr. Kevin Watkins will present his experience building a practice for minimally invasive pancreatico-duodenectomy. This symposium will include a video presentation as well as several key points to building and maintaining this procedure in practice.

Key Points Include:* Initial considerations and steps prior to first case* Tips on building a team* Best practices and key learnings* Sustaining hospital support — identifying the

differences in disposables for open and minimally invasive techniques

* Plans to improve for the future

Traditional Methods of hepatotomy: crush-clamp Technique and cusa. - Roderich Schwarz

Modern energy devices and Staplers: do They improve results? - N. Joseph Espat

laparoscopic hepatotomy Techniques: What Technologies are available? - David Geller

2:00 - 2:15 pm Break in ocean Tower 1 Foyer

2:15 - 2:45 PM IHPBA uPDATE - Professor o. James GardenRoom: Ocean Tower I A-C

SATURDAY

49

PROOF 4

2:45 - 3:45 pm

MOC AR

ahPBa Surgical Volunteerism and humanitarian outreach: capacity Building and lessons learnedRoom: Ocean Tower I A-CModerator: Gazi ZibariSponsored in part by the ahPBa Foundation

ahPBa executive council on The road lessons learned • Nicaragua Experience - J. Nicolas Vauthey • Costa Rica Experience - William Jarnagin • Ecuador Experience - William Chapman • Caribbean Island Experience - Elijah Dixon

Face to Face and Shoulder to Shoulder - Gazi Zibari

capacity Building in Kurdistan of iraq-Surgical house Staff Prospective- Ariel Dubose

3:45 - 4:30 PM PARAllEl DEBATES

Whipple is Preferred over the Frey Procedure for chronic PancreatitisRoom: Ocean Tower I A-CModerator: Syed AhmadProgram Supported by: angiodynamics

MOC

alPPS: associating liver Partition and Portal Vein ligation for Staged hepatectomyRoom: Ocean Tower II A/BModerator: Michael D’Angelica

MOC

Pro: david adams con: W. Scott helton Pro: eduardo de Santibañes

con: Jean-Nicolas Vauthey

4:30 - 5:15 PM PARAllEl uPDATE lECTuRES

electroporation of liver and Pancreas: Still experimental or accepted Practice?Room: Ocean Tower II A/BIntroduction: Robert Glasgow Presenter: Kevin CharpentierOpinion: Robert Martin

MOC

Transplantation for cholangiocarcinoma: Who and When?Room: Ocean Tower I A-CIntroduction: Alice Wei Presenter: Charles Rosen Opinion: Christopher Anderson

MOC AR

5:15 - 6:00 pm ahPBa Business MeetingRoom: Ocean Tower I A-C

6:15 - 7:45 PM oRAl PoSTER IIRoom: Promenade

oral Poster ii Pancreas aModerator: Sebastian de la Fuente

OP-B1.01 MANAGEMENT OF CELIAC ARTERY STENOSIS IN PANCREATICODUODENECTOMY S. Damle1, A. A. Alseidi1, T. R. Biehl1, W. S. Helton1, R. Moonka1, E. J. Raker2, D. Neuzil2, D. S. Pierce2, . , L. H. Quiroga1, . , F. G. Rocha1 ; 1HPB Service, Department of Surgery, Virginia Mason Medical Center, Seattle, WA; 2Vascular Surgery Service, Department of Surgery, Virginia Mason Medical Center, Seattle, WA

OP-B1.03 THE NEW STAPLING TECHNIQUE REINFORCED WITH THE ABSORBABLE SHEET FOR THE DISTAL PANCREATECTOMY I. Koyama1, K. Okamoto1, K. Okada1, M. Aikawa1, Y. Watanabe1, M. Miyazawa1 ; 1Saitama Medical University International Medical Center, Hidaka-shi, SAITAMA

OP-B1.04 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH PANCREATIC CANCER: A POPULATION-BASED STUDY C. J. Clark1, V. Zaydfudim2, S. Harmsen3, K. M. Reid-Lombardo2 ; 1Department of General Surgery, Winston-Salem, NC; 2Division of Gastroenterologic And General Surgery, Rochester, MN; 3Division of Biomedical Statistics And Informatics, Rochester, MN


SATURDAY

50

13th Annual Meeting

6:15 - 7:45 pm oral Poster ii - Room: Promenade Continued

oral Poster ii Pancreas a Continued

OP-B1.05 RADIOGRAPHIC CHANGES ASSOCIATED WITH SURGICAL RESECTION FOLLOWING NEOADJUVANT RADIATION THERAPY FOR LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA A. S. Dholakia1, A. Hacker-Prietz1, A. Wild1, S. Raman1, D. Laheru1, L. Zheng1, D. Le1, T. Pawlik1, M. Makary1, A. De Jesus-Acosta1, C. Wolfgang1, J. Herman1 ; 1Johns Hopkins University School of Medicine, Baltimore, MD

OP-B1.06 CHARACTERIZATION OF PANCREATIC ADENOCARCINOMA OF PRIMARY AND PERITONEAL METASTASIS A PILOT STUDY USING BIOMARKERS FOR METASTASIS (EMT) A. Abrams1, T. Jie1, E. Ong1, R. Heimark1, A. Bhattacharyya2, C. Patel2 ; 1University of Arizona Department of Surgery, Tucson, ARIZONA; 2University of Arizona Department Pathology, Tucson, ARIZONA

OP-B1.07 ELEVATED HEMOGLOBIN A1C IN THE DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA AND THE RELATIONSHIP TO POSTOPERATIVE MORBIDITY AND DIABETES K. C. Hewitt1, M. C. Mone1, S. J. Mulvihill1, C. L. Scaife1 ; 1University of Utah , Salt Lake City, UTAH

OP-B1.08 IS TOTAL PANCREATECTOMY FOR DUCTAL ADENOCARCINOMA OF THE HEAD OF THE PANCREAS JUSTIFIED BASED ON THE RISK OF TUMOR MULTICENTRICITY? A. Andreou1, T. Denecke2, M. Bahra1, F. Klein1, P. Warnick1, P. Neuhaus1, M. Glanemann1 ; 1Department of General, Visceral And Transplantation Surgery, Charit魕niversit魕medizin Berlin, Berlin, BERLIN; 2Klinik Fr Strahlenheilkunde, Charit魕niversit魕medizin Berlin, Berlin, BERLIN

oral Poster ii liver aModerator: Kevin Staveley-O’Carroll

OP-B2.01 ANALYSIS OF PRE-OPERATIVE RISK FACTORS PREDICTIVE OF REOPERATIONS WITHIN 30 DAYS IN PATIENTS UNDERGOING HEPATIC RESECTIONS FOR MALIGNANCY M. Dhir1, L. M. Smith2, G. W. Dittrick3, C. Are1 ; 1University of Nebraska Medical Center, Omaha, NE; 2University of Nebraska Medical Center, Omaha, NE; 3Nebraska Methodist Hospital, Omaha, NE

OP-B2.02 OPTIMAL ABLATION VOLUMES ARE ACHIEVED AT SUB-MAXIMAL POWER SETTINGS IN A 2.45GHZ MICROWAVE ABLATION SYSTEM D. J. Niemeyer1, K. A. Simo1, M. McMillan1, E. M. Hanna1, J. H. Swet1, D. Sindram1, J. B. Martinie1, I. H. McKillop1, D. A. Iannitti1 ; 1Carolinas Medical Center, Charlotte, NC

OP-B2.03 ZBP-89 FACILITATES DEATH OF HEPATOCELLULAR CARCINOMA CELLS VIA MULTIPLE CHANNELS G. G. Chen1, C. Ye1, C. Z. Zhang1, P. B. Lai1 ; 1The Chinese University of Hong Kong, Shatin, NT

OP-B2.04 HEPATECTOMY FOR BENIGN PATHOLOGY IN 112 PATIENTS AT A SINGLE TERTIARY CARE INSTITUTION S. D. Nichols1, C. R. Schmidt1, E. W. Martin1, P. Muscarella2, W. S. Melvin2, E. C. Ellison2, M. Bloomston1 ; 1The Ohio State University, Wexner Medical Center, Columbus, OH; 2The Ohio State University, Wexner Medical Center, Columbus, OH

OP-B2.05 THE ANALYSIS OF FACTORS UPON VOLUMETRICAL AND FUNCTIONAL LIVER REGENERATION AFTER LIVER RESECTION. M. Taniguchi1, K. Watanabe1, T. Einama1, K. Imai1, H. Furukawa1 ; 1Division of Gastroenterologic And General Surgery, Asahikawa Medical University, Asahikawa, HOKKAIDO

OP-B2.06 THE IMPACT OF SURGICAL MARGIN STATUS ON OUTCOME AFTER HEPATIC RESECTION FOR COLORECTAL METASTASIS S. Kaihara1, K. Inoguchi1, R. Hosotani1 ; 1Kobe City Medical Menter General Hospital, Kobe, HYOGO

OP-B2.07 COMBINED ORTHOTOPIC LIVER TRANSPLANT WITH PANCREATICODUODENECTOMY M. G. Mesleh1, J. A. Stauffer1, H. J. Asbun1, J. H. Nguyen1 ; 1Mayo Clinic Florida, Jacksonville, FL

OP-B2.08 EVALUATION OF RESISTANCE AS A MEASURE OF SUCCESSFUL TUMOR ABLATION DURING IRREVERSIBLE ELECTROPORATION E. M. Dunki-Jacobs1, P. Philips1, C. R. Scoggins1, G. G. Callender1, K. M. McMasters1, R. C. Martin1 ; 1University of Louisville, Louisville, KY

SATURDAY

51

PROOF 4

6:15 - 7:45 pm oral Poster ii - Room: Promenade Continued

oral Poster ii Tricks of the Trade aModerator: Robert Glasgow

OP-B3.01 PROGNOSTIC SIGNIFICANCE OF PET TAC IN NEUROENDOCRINE TUMOR OF THE PANCREAS H. Duran1, E. Vicente1, Y. Quijano1, B. Ielpo1, E. Diaz1, I. Fabra1, R. Puga1, C. Oliva1, R. Caruso1, V. Ferri1, J. Plaza1, L. Garcia1, J. Rodriguez1, S. Olivares1 ; 1Sanchinarro University Hospital, Madrid, MADRID

OP-B3.02 A CT-BASED METHOD OF PREDICTING PANCREATIC FISTULA BEFORE PANCREATECTOMY W. Johnston1, J. Shen1, C. Mathews1, M. Cassera1, S. Cho1, C. Hammill1, R. Wolf1, P. Hansen1, P. Newell1 ; 1Providence Portland Medical Center, Portland, OR

OP-B3.03 RISK ASSESSMENT OF PANCREATIC FISTULA AFTER PANCTRATICODUODENECTOMY BY MEASURING OF PURE PANCREATIC JUICE AMYLASE LEVEL K. Imai1, M. Furukori1, K. Watanabe1, T. Einama1, M. Taniguchi1, H. Furukawa1 ; 1Division of Gastroenterologic And General Surgery Asahikawa Medical University, Asahikawa, HOKKAIDO

OP-B3.04 USING IMAGE-GUIDANCE AND 3-D MODELS FOR NEEDLE PLACEMENT DURING IRE-NANOKNIFE SURGERIES R. C. Martin1, J. D. Stefansic2, B. W. Neese2, P. Dumpuri2 ; 1University of Louisville, KY, Louisville, KY; 2Pathfinder Therapeutics, Nashville, TN

OP-B3.05 INTRAOPERATIVE ESTIMATED BLOOD LOSS PREDICTS NEED FOR ICU CARE: A SINGLE CENTER EXPERIENCE H. Osman1, A. Thomas1, D. R. Jeyarajah1 ; 1Methodist Dallas Medical Center, Dallas, TEXAS

OP-B3.06 CORRECTION OF PRE-OPERATIVE ANEMIA WITHOUT BLOOD PRODUCTS MAY REDUCE THE NEED TO TRANSFUSE PATIENTS AFTER A PANCREATICODUODENECTOMY A. J. Rubinstein 1, C. Devulapalli1, J. A. Graham1, A. B. Parker1, L. B. Johnson1 ; 1Georgetown University Hospital, Washington, DC

OP-B3.07 THE NEED FOR JEJUNAL FEED OR TPN AFTER PANCREATICODUODENECTOMY (PD): IS IT PREDICTABLE? H. Osman1, A. Thomas1, D. R. Jeyarajah1 ; 1Methodist Dallas Medical Center, Dallas, TEXAS

OP-B3.08 MANAGEMENT OF MEDIASTINAL PANCREATIC PSEUDOCYSTS: A CASE REPORT AND REVIEW OF THE LITERATURE D. V. Hughes1, R. L. Harmon1, J. P. Arnoletti1, W. S. Eubanks1, S. G. De La Fuente1 ; 1Florida Hospital Orlando, Orlando, FL

oral Poster ii Tricks of the Trade BModerator: Dirk Gouma

OP-B4.01 MAKING HEPATIC TRISECTIONECTOMIES FOR HILAR CHOLANGIOCARCINOMA SAFER BY RETAINING SUB-SEGMENT 4A A. A. Alseidi1, F. G. Rocha1, S. .. Damle1, W. S. Helton1 ; 1Virginia Mason Medical Center, Seattle, WA

OP-B4.02 LAPAROSCOPIC VISUALIZATION OF LESIONS AT THE HEPATIC DOME USING NOVEL TELESCOPES: VARIABLE-DIRECTION-OF-VIEW TELESCOPE AND DEFLECTABLE TELESCOPE N. N. Nissen1, V. G. Menon1 ; 1Cedars-Sinai Medical Center, Los Angeles, CALIFORNIA

OP-B4.03 BILIARY PERITONITIS DUE TO GASTRIC WALL PERFORATION AND LIVER PENETRATION AFTER SWALLOWING OF FOREIGN BODY L. M. VELTCHEV1 ; 1State Hospital , Biala Slatina , VRATZA; 2Privat Hospital “Clement Drevon,” Dijon, BOURGUNDY

OP-B4.04 SURGICAL INTERVENTION FOR INTRADUCTAL HEPATOCELLULAR CARCINOMAS CAUSING JAUNDICE SECONDARY TO BILIARY OBSTRUCTION Y. Koh1, S. Lee1,2, A. Chok1, A. Chung1 ; 1Department of General Surgery Singapore General Hospital , SG, SG; 2Department of Surgical Oncology National Cancer Centre, SG, SG


SATURDAY

52

13th Annual Meeting

6:15 - 7:45 pm oral poster ii - Room: Promenade Continued

oral Poster ii Tricks of the Trade B

OP-B4.05 ECHINOCOCCAL LIVER DISEASE IN NEW YORK; AN IMPORTED PROBLEM L. Gutnik1, M. Vivanco1, C. Coyle1, J. Chapochnick Friedmann1 ; 1Montefiore Medical Center - Albert Einstein College of Medicine, Bronx, NY

OP-B4.06 ASSOCIATION OF CONGENITAL PORTOSYSTEMIC SHUNT (CEPS) WITH HEPATOMA A. REGE1, P. Suhocki1, C. Berg1, D. Sudan1, K. Ravindra1, . ; 1Duke University Medical Center, Durham, North Carolina

OP-B4.07 HEPATIC ADENOMATOSIS PRESENTING WITH HEMORRHAGIC SHOCK: A CASE REPORT AND REVIEW OF THE LITERATURE B. M. Amundsen1, J. A. Greene1, L. Bijelic1 ; 1MedStar Washington Hospital Center, Washington, DC

OP-B4.08 COMPARISON OF TECHNIQUES FOR VOLUMETRIC ANALYSIS OF THE FUTURE LIVER REMNANT: IMPLICATIONS FOR MAJOR HEPATIC RESECTIONS G. Martel1, R. Huang1, A. Belblidia1, M. Dagenais1, R. Lapointe1, F. Vandenbroucke-Menu1 ; 1HPB Surgery And Liver Transplantation Unit, Hal Saint-Luc, Universit魕e Montr魕, Montreal, QC

oral Poster ii Pancreas BModerator: Paul Hansen

OP-B5.01 THREE-DIMENSIONAL (3-D) CT FOR VIRTUAL SIMULATION/SURGICAL PLANNING OF PANCREATIC NEUROENDOCRINE TUMORS ENUCLEATION VS. RESECTION A. V. Maker1, V. K. Maker1 ; 1University of Illinois At Chicago, Department of Surgery, Division of Surgical Oncology, Chicago, IL

OP-B5.02 TOTAL PANCREATO DUODENECTOMY WITH PORTACAVAL SHUNT FOR THE TREATMENT OF A PANCREATIC NEUROENDOCRINE TUMOR WITH PORTAL HYPERTENSION M. Palavecino1, P. Pellegrini1, G. Arbues1, P. Perez Mesa1, J. Pekolj1 ; 1Hospital Italiano De Buenos Aires, Buenos Aires, BUENOS AIRES

OP-B5.03 HEPATO-PANCREATO-BILIARY (HPB) SURGERY FELLOWS: WHAT IS AFTER FELLOWSHIP? A SINGLE FELLOWSHIP EXPERIENCE H. Osman1, D. R. Jeyarajah1 ; 1Methodist Dallas Medical Center, Dallas, TEXAS

OP-B5.04 ROCK-STAR AND OTHER SHOCKINGLY UNCOMMON CAUSES OF PANCREATITIS? A. Abdo1, S. C. Cunningham1 ; 1Saint Agnes Hospital, Baltimore, MD

OP-B5.05 HISTOPATHOLOGICAL ANALYSIS OF NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS M. Furukouri1, K. Watanabe1, T. Einama1, K. Imai1, H. Furukawa1, M. Taniguchi1 ; 1Division of Gastroenterologic And General Surgery, Asahikawa Medical Univ, Asahikawa, HOKKAIDO

OP-B5.06 SURGICAL TREATMENT OF PANCREATIC NEUROENDOCRINE TUMORS: CLINICOPATHOLOGIC FEATURES E. Ramos Figueira1, T. Bacchella1, J. A. Rocha Filho2, A. V. Fernandes3, J. Okubo3, R. Jureidini1, U. Ribeiro1, I. Cecconello1 ; 1Discipline of Digestive Surgery, Department of Gastroenterology, Hospital Das Clinicas FMUSP, Sao Paulo, SP; 2Discipline of Anesthesiology, University of Sao Paulo School of Medicine, Sao Paulo, SP; 3Scientific Initiation, University of Sao Paulo School of Medicine, Sao Paulo, SP

OP-B5.07 AMPULLARY PANCREATIC TYPE CANCER METASTATIC TO THE ANAL CANAL: A UNIQUE CASE F. Ejtehadi1, N. A. Chatzizacharias1, R. Brais2, A. Jah1 ; 1Department of HPB And Transplant Surgery, Cambridge, Cambridgeshire; 2Department Of Histopathology, Cambridge, Cambridgeshire

SATURDAY

53

PROOF 4

6:15 - 7:45 pm oral poster ii - Room: Promenade Continued

oral Poster ii liver BModerator: Emily Winslow

OP-B6.01 LUNG AND LIVER RESECTION FOR COLORECTAL METASTASES: A SURVIVAL ANALYSIS S. Coughlin1, K. P. Croome1, R. A. Malthaner1, R. Hernandez-Alejandro1 ; 1Western University Canada, London, ON

OP-B6.02 INITIAL EXPERIENCE WITH ROBOTIC LIVER RESECTIONS S. G. Carpenter1, E. P. Castle1, P. E. Andrews1, N. N. Katariya1, D. C. Mulligan1 ; 1Mayo Clinic Arizona , Phoenix, AZ

OP-B6.03 3-D ADVANCED IMAGING FOR DETAILED DELINEATION OF LIVER SEGMENTAL ANATOMY IN PRE-SURGICAL PLANNING S. Rahmanuddin1, Y. Genyk1, H. Anoushiravan1, D. Tahour1, S. Cen1, G. Whang1, V. Duddalwar1, S. Palmer1 ; 1Keck Medical Center , University of Southern California, Los Angeles, CA

OP-B6.04 CLINICAL AND FINANCIAL CONSIDERATIONS OF ESTABLISHING A HEPATOBILIARY CENTER DURING AN ECONOMIC CRISIS G. Tsoulfas1, E. Kastanias1, A. Toolias1, S. Kalamaras1, G. Marakis1 ; 1First Department Of Surgery, Aristotle University Of Thessaloniki, Thessaloniki, Thessaloniki

OP-B6.05 RECOVERY OF HEPATIC FUNCTION AFTER GIANT HEPATIC ARTERY ANEURYSMECTOMY WITHOUT REVASCULARIZATION E. Vega1, L. T. Chin2, G. Vedula2 ; 1Florida Hospital General Surgery Residency , Orlando, FL; 2Florida Hospital Transplant Center, Orlando, FL

OP-B6.06 A STEPWISE APPROACH TO RESECTION IN HEPATIC ADENOMATOSIS C. Yazici1, D. J. Niemeyer1, M. T. Lavelle1, D. Iannitti1, M. W. Russo1 ; 1Carolinas Medical Center, Charlotte, NC

OP-B6.07 IMAGE GUIDED PARENCHYMAL TRANSECTION REDUCES BLOOD LOSS DURING THE FIRST YEAR OF SOLO HPB PRACTICE J. Mandell1, K. Lowe1 ; 1Akron General Medical Center, Akron, OH

OP-B6.08 PRIMARY HEPATIC LEIOMYOSARCOMA: SHOULD AN INTERNATIONAL DATABASE BE ESTABLISHED FOR BETTER STANDARD OF CARE? R. Wijaya1, L. Lee1, S. Tan1, S. Tan1 ; 1Changi General Hospital, Singapore, SINGAPORE

oral Posters ii Biliary/otherModerator: Kadiyala Ravindra

OP-B7.02 FLUOROSCOPY ASSISTED LAPAROSCOPIC CHOLECYSTECTOMY IN A PATIENT WITH A HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE D. L. Eck1, E. V. Belli1, S. L. Koonce1, H. J. Asbun1, J. A. Stauffer1 ; 1Mayo Clinic, Jacksonville, FL

OP-B7.03 INTRAHEPATIC INTRADUCTAL PAPILAR MUCINOUS NEOPLASIA OF THE BILE DUCTS; A CASE SERIES OF THIS UNFREQUENT ENTITY M. Vivanco1, L. Gutnik1, B. Wengerter1, M. Kinkhabwala1, S. Bellemare1, J. Chapochnick Friedmann1 ; 1Montefiore Medical Center - Albert Einstein College of Medicine, Bronx, NY

OP-B7.04 INTRADUCTAL PAPILLARY NEOPLASM OF THE BILE DUCT A. Kamyab1, M. J. Jacobs1 ; 1Providence Hospital And Medical Centers, Southfield, MI

OP-B7.05 SURGICAL TREATMENT OF BENIGN BILIOPANCREATIC DISEASES IN PATIENTS OVER 60 YEARS E. Ramos Figueira1, T. Bacchella1, J. A. Rocha Filho2, C. N. Carneiro3, A. R. Assalin4, M. R. Ciongoli3, R. Jureidini1, I. Cecconello1 ; 1Discipline of Digestive Surgery, Department of Gastroenterology, Hospital Das Clinicas FMUSP, Sao Paulo, SP; 2Discipline of Anesthesiology, University of Sao Paulo School of Medicine, Sao Paulo, SP; 3Scientific Initiation, University of Sao Paulo School of Medicine, Sao Paulo, SP; 4Scientific Initiation FAPESP 2011/22470-3, University of Sao Paulo School of Medicine, Sao Paulo, SP

OP-B7.06 INCIDENCE OF POST-OPERATIVE INFECTIOUS COMPLICATIONS IN COMPLEX HEPATOBILIARY SURGERY UTILIZING PREOPERATIVE BROAD SPECTRUM ANTIBIOTIC AND ANTIFUNGAL COVERAGE IN CONJUNCTION WITH INTRAOPERATIVE CULTURES. A. H. Fathi1, K. Siegel1, C. Siegel1 ; 1Case Western Reserve University, Cleveland Hghts, OHIO


SATURDAY

54

13th Annual Meeting

7:30 - 9:30 PM PARAllEl EDuCATIonAl DInnER SyMPoSIA

Emerging Therapeutic Approaches to Intrahepatic CholangiocarcinomaRoom: Ocean Tower II A-BModerators: Timothy Pawlik and Shishir Maithel

MOC

Pancreatic Pseudocysts: Is the Surgeon necessary? Room: Ocean Tower II CModerator: Nicholas Zyromski

MOC

Surgical resection of intrahepatic cholangiocarcinoma: Patient Selection, Pre-operative considerations and operative Technique - Timothy Pawlik

Pseudocyst historical Perspective: Scalpels, not Scopes - Kevin Behrns

imaging of intrahepatic cholangiocarcinoma: diagnostic Work-up and assessment of response - Ihab Kamel

contemporary endoscopic Perspective - Gregory Cote

loco-regional therapy of intrahepatic cholangiocarcinoma: intra-arterial therapy, radiation Therapy. does any of it Make Sense? - T. Clark Gamblin

crossing Boundaries: Surgeons and endoscopists Working Together - John Christein

Systemic Treatment of intrahepatic cholangiocarcinoma: Where do We Stand? - Melanie Thomas

We’re in the 21St century - does laparoscopy change the Playing Field? - Katherine Morgan

case Presentations

SATURDAY

55

PROOF 4

7:00 - 8:30 am Breakfast - Bloody Mary’s & Mimosas will be served.

7:30 - 11:00 am registration desk open Ocean Tower I Foyer

7:30 - 11:00 am Speaker ready room Room: San Marco

7:30 - 8:30 AM PARAllEl CoMPETITIVE VIDEoS

liverRoom: Ocean Tower I BModerators: Paulo Herman & Sean Kumer

MOC

Pancreas/BiliaryRoom: Ocean Tower I AModerators: Emily Winslow & Brendan Visser

MOC

competitive Video i-a - liver Room: Ocean Tower I BModerators: Paulo Herman & Sean Kumer

MOC

CV1.01 ROBOTIC-ASSISTED RIGHT HEPATIC RESECTION, EXTRAHEPATIC VEIN LIGATION M. S. Sabbaghian1, D. L. Bartlett1, A. Tsung1 ; 1University of Pittsburgh Medical Center, Pittsburgh, PA

CV1.02 ASSOCIATING LIVER PARTITION AND PORTAL VEIN LIGATION FOR STAGE HEPATECTOMY (ALPPS). A MODERN APPROACH FOR AVOIDING POSTOPERATIVE LIVER FAILURE. V. Ardiles1, S. Sala1, F. Alvarez1, J. Pekolj1, E. De Santibanes1 ; 1HPB And Liver Transplantation Unit. Hospital Italiano De Buenos Aires, Buenos Aires, BUENOS AIRES

CV1.03 A SIMPLE SYSTEM FOR VIDEO OF OPEN SURGICAL CASES N. N. Nissen1, V. G. Menon1, J. A. Williams1, G. Berci1 ; 1Cedars-Sinai Medical Center, Los Angeles, CALIFORNIA

CV1.04 RADICAL SURGERY OF LIVER TUMORS INVOLVING HEPATIC VENOUS OUTFLOW WITH AND WITHOUT HIPOTHERMIC PROTECTION E. Vicente1, Y. Quijano1, B. Ielpo1, H. Duran1, E. Diaz1, I. Fabra1, R. Puga1, C. Oliva1, R. Caruso1, V. Ferri1, J. Plaza1, B. Alvarez1, S. Olivares1 ; 1Sanchinarro University Hospital, Madrid, MADRID

competitive Video i-B - Pancreas/Biliary Room: Ocean Tower I AModerators: Emily Winslow & Brendan Visser

MOC

CV2.01 TECHNIQUE OF LAPAROSCOPIC CHOLEDOCHODUODENOSTOMY M. G. Mesleh1, H. J. Asbun1, J. A. Stauffer1 ; 1Mayo Clinic Florida, Jacksonville, FL

CV2.02 HYBRID LAPAROSCOPIC-ROBOTIC PANCREATICODUODENECTOMY AS AN INSTRUCTIONAL VIDEO K. M. El-Hayek1, S. Chalikonda1, R. Walsh1 ; 1Cleveland Clinic, Cleveland Heights, OH

CV2.03 POSTERIOR SMA FIRST APPROACH FOR RESECTION OF LOCALLY ADVANCED PANCREATIC CANCER J. Rose1, F. Rocha1, A. Alseidi1, T. Biehl1, S. Helton1 ; 1Virginia Mason Medical Center, Seattle, WA

CV2.04 ROBOTIC TRANSGASTRIC CYSTGASTROSTOMY AND PANCREATIC DEBRIDEMENT K. A. Simo1, R. Z. Swan1, D. Sindram1, D. A. Iannitti1, J. B. Martinie1 ; 1Carolinas Medical Center, Charlotte, NC


SUNDAY

56

13th Annual Meeting

8:30 - 9:30 AM SyMPoSIuM By THE CoMMITTEE on SuRGICAl InnoVATIon (CSI) Ocean Tower 1B

MOCWhat is the committee for Surgical innovation? - James A. Moser

New developments in cold and Normothermic liver Perfusion in cadaveric liver Transplantation - Majella DoyleSpanning the Gap Between Unmet Need and Technology-Based Solutions:Pathways and Barriers to New device deployment - Meghan Dierks and Stan Finkelstein

Panel discussion Jim Moser, Majella Doyle, Meghan Dierks, Stan Finkelstein

Summary of Session:on a daily basis, surgeons encounter new challenges and identify opportunities where novel technology could help them be more clinically effective. in the US, however, the process of getting new technology into the hands of clinicians is long, and there can be many barriers to success. ideas conceived of at the point of care must find a path (and effective partnerships) to successful commercialization and regulatory clearance. ideas conceived of on corporate whiteboards must find a path (and effective partnerships) to the clinical environment in order to access the specialized knowledge of front-line providers and patients necessary to generate the clinical effectiveness, performance and safety data. in this session, we will discuss some of the factors that slow process of getting innovating and cutting-edge¹ technology into hands of clinicians, and why. Finally, in the panel discussion, we will explore the possible role of professional societies and clinician consortia (such as the ahBPa’s committee for Surgical innovation) can play in reducing the barriers to success.

8:30 - 10:30 AM PARAllEl ABSTRACT PRESEnTATIonS

long oral ii-d - Pancreas iiRoom: Ocean Tower I AModerators: William Hawkins & Clifford Cho

Mini oral a - liver TransplantRoom: Ocean Tower I CModerators: Jennifer Lafemina & Lee Thompson

long oral ii-d - Pancreas ii

O2-D.01 SERUM CA 19-9 REPRESENTS A MARKER OF RESPONSE TO NEOADJUVANT THERAPY IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER C. D. Tzeng1, J. B. Fleming1, J. E. Lee1, P. W. Pisters1, T. A. Aloia1, J. N. Vauthey1, R. A. Wolff2, G. Varadhachary2, C. H. Crane3, M. H. Katz1 ; 1The University of Texas MD Anderson Cancer Center, Houston, TX; 2The University of Texas MD Anderson Cancer Center, Houston, TX; 3The University of Texas MD Anderson Cancer Center, Houston, TXdiscussant: Quyen d. chu

O2-D.02 ANTECOLIC VS. RETROCOLIC GASTRO/DUODENOJEJUNOSTOMY AND DELAYED GASTRIC EMPTYING (DGE) AFTER PANCREATICODUODENECTOMY A. D. Parmar1,4, K. M. Sheffield1, G. M. Vargas1, H. A. Pitt2, E. M. Kilbane2, B. L. Hall3, T. S. Riall1 ; 1University of Texas Medical Branch, Galveston, TX; 2Indiana University School of Medicine, Indianapolis, IN; 3Washington University School of Medicine, St. Louis, MO; 4University of California San Francisco-East Bay, Oakland, CAdiscussant: Trey Blazer

O2-D.03 ASSESSING THE IMPACT OF FISTULAS AFTER PANCREATICODUODENECTOMY USING THE POSTOPERATIVE MORBIDITY INDEX (PMI) B. C. Miller1, J. D. Christein2, M. P. Callery3, J. A. Drebin1, T. S. Kent3, W. B. Pratt3, C. M. Vollmer1 ; 1Department of Surgery, Hospital of The University of Pennsylvania, University of Pennsylvania , Philadelphia , PA; 2Department of Surgery, University of Alabama At Birmingham School of Medicine, Birmingham, AL; 3Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MAdiscussant: clark Gamblin

O2-D.04 DEEP SEQUENCING ANALYSIS OF MICROBIAL DNA IN INFECTED NECROTIZING PANCREATITIS E. M. Hanna1, I. H. McKillop1,2, F. K. Bahrani-Mougeot1, A. Fodor2, T. Hamp2, J. B. Martinie1, D. Sindram1, D. A. Iannitti1 ; 1Carolinas Medical Center, Charlotte, NC; 2UNC At Charlotte, Charlotte, NCdiscussant: Stephen Behrman

SUNDAY

57

PROOF 4


long oral ii-d - Pancreas ii - Continued

O2-D.06 IS IT WORTH THE RISK: THE MORBIDITY OF TOTAL PANCREATECTOMY WITH AUTO-ISLET CELL TRANSPLANTATION COMPARED TO TOTAL PANCREATECTOMY ALONE N. H. Bhayani1, E. T. Kimchi1, K. F. Staveley-OCarroll1, N. J. Gusani1 ; 1Section of Surgical Oncology, Department of Surgery, Penn State Hershey Cancer Institute, Hershey, PAdiscussant: Satish N. Nadig

O2-D.07 RANKINGS VS. REALITY FOR PANCREATIC CANCER SURGERY: A REAL WORLD COMPARISON Z. Chau1, J. K. West4, Z. Zhou3, T. P. McDade1, J. K. Smith1, S. C. Ng2, T. S. Kent2, M. P. Callery2, A. J. Moser2, J. F. Tseng2 ; 1University of Massachusetts Medical School, Worcester, MA; 2Beth Israel Deaconess Medical Center- Harvard Medical School, Boston, MA; 3Northwestern University Robert H. Lurie Cancer Center, Chicago, IL; 4Massachusetts Department of Public Health, Boston, MAdiscussant: christopher Wolfgang

O2-D.08 DOES REGIONAL VARIATION IMPACT DECISION MAKING IN THE MANAGEMENT AND PALLIATION OF PANCREATIC HEAD ADENOCARCINOMA? C. G. Ball1, V. Hurdle1, J. Ouellet1, E. Dixon1, T. J. Howard2, K. D. Lillemoe3 ; 1University of Calgary, Calgary, ALBERTA; 2Indiana University, Indianapolis, INDIANA; 3Harvard University, Boston, MASSACHUSETTSdiscussant: Jennifer Tseng

Mini oral a - liver/Transplant

MO-A.01 MICROWAVE ABLATION HAS LOWER LOCAL RECURRENCE RATES THAN RADIOFREQUENCY ABLATION AFTER TREATMENT OF COLORECTAL LIVER METASTASIS. A MATCHED COHORT ANALYSIS. C. Correa-Gallego1, Y. Fong1, M. Gonen1, M. I. D’Angelica1, P. J. Allen1, R. P. DeMatteo1, W. R. Jarnagin1, T. P. Kingham1 ; 1Memorial Sloan-Kettering Cancer Center, New York, NY

MO-A.02 THE IMPACT OF UNDERLYING VIRAL DISEASE ON OUTCOMES AFTER LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA: THE RESULTS FROM A NORTH AMERICAN CENTRE J. Lee1, P. T. Kim1, S. Fung2, S. Gallinger1, I. McGilvray1, C. Moulton1, A. C. Wei1, P. D. Greig1, S. P. Cleary1 ; 1University of Toronto, Department of General Surgery, Toronto, ONTARIO; 2University of Toronto, Division of General Internal Medicine, Toronto, ON

MO-A.03 DOES TYPE OF COLORECTAL PROCEDURE IMPACT COMPLICATION RATES FOLLOWING COMBINED LIVER AND COLORECTAL RESECTIONS FOR METASTATIC COLORECTAL CANCER? ANALYSIS OF AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (ACS NSQIP) S. W. Cho1, W. C. Johnston1, M. A. Cassera1, P. H. Newell1, C. W. Hammill1, M. Whiteford1, R. F. Wolf1, P. D. Hansen1 ; 1Providence Portland Medical Center, Portland, OR

MO-A.04 LAPAROSCOPIC RADIOFREQUENCY ABLATION OF LIVER METASTASES FROM BREAST CANCER Y. Tasci1, E. Aksoy1, H. Moore1, H. E. Taskin1, S. Aliyev1, O. Agcaoglu1, A. Siperstein1, E. Berber1 ; 1Cleveland Clinic, Cleveland, OHIO

MO-A.05 LAPAROSCOPIC VENTRAL HERNIA REPAIR IN THE CIRRHOTIC PATIENT, A SAFE ALTERNATIVE B. A. Wormer1, P. D. Colavita1, J. F. Bradley1, K. B. Williams1, A. L. Walters1, V. A. Augenstein1, B. T. Heniford1 ; 1Carolinas Medical Center, Charlotte, NC

MO-A.06 PORTAL VEIN THROMBOSIS SECONDARY TO HEPATOPANCREATICOBILIARY MALIGNANCY: AN ASSESSMENT OF INCIDENCE, RISK FACTORS, AND CLINICAL MANAGEMENT E. M. Dunki-Jacobs1, E. E. Priddy1, P. Philips1, M. E. Egger1, C. R. Scoggins1, G. G. Callender1, K. M. McMasters1, R. C. Martin1 ; 1University of Louisville, Louisville, KY

MO-A.07 INCIDENCE AND OUTCOMES OF HEPATOBLASTOMAS IN CHILDREN B. J. Allan1, E. A. Perez1, H. L. Neville1, J. E. Sola1 ; 1University of Miami, Miami, FL

MO-A.08 FACTORS AFFECTING LIKELIHOOD OF SURGICAL REFERRAL FOR HEPATIC MALIGNANCIES A. P. Chidi1, D. A. Geller1, C. L. Bryce2, A. Tsung1 ; 1University of Pittsburgh School of Medicine, Pittsburgh, PA; 2University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA


SUNDAY

58

13th Annual Meeting


Mini oral a - liver/Transplant Continued

MO-A.09 MULTI-INSTITUTION ANALYSIS OF SURVIVAL AFTER HEPATECTOMY FOR FIBROLAMELLAR CARCINOMA R. T. Groeschl1, R. K. Wong1, C. H. Pilgrim1, M. Bloomston2, M. E. Lidsky3, B. M. Clary3, R. C. Martin4, J. F. Buell5, G. Belli6, T. Gamblin1 ; 1Medical College of Wisconsin, Milwaukee, WI; 2Ohio State University, Columbus, OH; 3Duke University, Durham, NC; 4University of Louisville, Louisville, KY; 5Tulane University, New Orleans, LA; 6Loreto Nuovo Hospital, Napoli, NA

MO-A.10 MINIMALLY INVASIVE RESECTION OF COLORECTAL CANCER LIVER METASTASES SHORTENS THE INTERVAL TO INITIATION OF ADJUVANT SYSTEMIC CHEMOTHERAPY: A CASE-CONTROL STUDY B. J. Golas1, S. Li1, S. K. Reddy1, J. Steel1, J. C. Mejia1, J. F. Pingpank2, J. W. Marsh1, D. L. Bartlett2, D. A. Geller1, A. Tsung1 ; 1UPMC Liver Cancer Center, Starzl Transplant Institute, Pittsburgh, PA; 2University of Pittsburgh Medical Center, Pittsburgh, PA

MO-A.11 LAPAROSCOPIC MICROWAVE ABLATION OF LIVER TUMORS USING 3D GUIDANCE SYSTEM IN HUMANS D. Sindram1, K. A. Simo1, R. Z. Swan1, D. J. Niemeyer1, S. B. Lee1, I. H. McKillop1, D. A. Iannitti1, J. B. Martinie1 ; 1Carolinas Medical Center, Charlotte, NC

MO-A.12 TREATMENT SEQUENCING STRATEGY FOR HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA R. M. Thomas1, M. J. Truty2, E. Choi3, S. A. Curley1, J. Vauthey1, E.K. Abdalla4, T. A. Aloia1 ; 1The University of Texas MD Anderson Cancer Center, Houston, TX; 2Mayo Clinic, Rochester, MN; 3The University of Chicago, Chicago, IL; 4University Medical Center, Achrafieh, BEIRUT

MO-A.13 INCIDENCE OF COAGULOPATHY DURING HEPATECTOMIES AND THE EFFECT OF EPIDURAL USE ON POSTOPERATIVE COMPLICATIONS A. Amini1, A. E. Patanwala1, E. S. Glazer1, G. H. Skrepnek1, T. Jie1, R. W. Gruessner1, E. S. Ong1 ; 1University of Arizona, Tucson, AZ

MO-A.14 NON-INVASIVE PREOPERATIVE QUANTIFICATION OF HEPATIC STEATOSIS USING A NOVEL MRI TECHNIQUE: 100% ACCURACY CONFIRMED WITH PATHOLOGIC ASSESSMENT T. A. Aloia1, G. Zimmitti1, J. Ma1, P. Hou1, A. Rashid1, S. A. Curley1, J. Vauthey1, H. Choi1 ; 1UT MD Anderson Cancer Center, Houston, TEXAS

MO-A.15 CLINICO-PATHOLOGICAL FACTORS ASSOCIATED WITH PROGNOSIS IN PRIMARY INTRA-HEPATIC CHOLANGIOCARCINOMA: A SINGLE CENTER EXPERIENCE Z. S. Kanji1,2, N. Devaud1, S. Gallinger1, S. P. Cleary1 ; 1Department Of General Surgery, University Health Network, Toronto, Ontario; 2Department Of General Surgery, Vancouver, BC

MO-A.16 DISTINCTIVE LYSOPHOSPHATIDIC ACID RECEPTOR EXPRESSION IN HEPATOCELLULAR CARCINOMA N. J. Skill1, J. Wu1, M. A. Maluccio1 ; 1Indiana University, Indianapolis, INDIANA

MO-A.17 THE EFFECT OF INTRA-OPERATIVE STENTING ON BILIARY COMPLICATIONS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION A. K. Mathur1, S. N. Nadig1, T. H. Welling1 ; 1University of Michigan, Ann Arbor, MI

MO-A.18 WHEN THE OUTFLOW SLOWS: TECHNICAL AND DIAGNOSTIC CONSIDERATIONS FOR THE HEPATIC VENOUS ANASTAMOSIS IN PEDIATRIC LIVER TRANSPLANTATION J. Sommovilla1, M. M. Doyle1,2, N. Vachharajani1, N. Saad1, M. Nadler2, Y. P. Turmelle1,2, A. Weymann1,2, W. C. Chapman1,2, J. A. Lowell1,2 ; 1Washington University, St Louis, St Louis, Mo; 2St Louis Children’s Hospital, St Louis, MO

MO-A.19 THE VALIDATION OF A CLASSIFICATION SYSTEM FOR BILIARY COMPLICATIONS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION (OLT) A. Neville1, M. Boutros1, J. Barkun1 ; 1McGill University Health Centre, Montreal, QC

MO-A.20 NATIONALLY PLACED HIGH-RISK LIVER ALLOGRAFTS ARE A COST-EFFECTIVE MECHANISM OF INCREASING PATIENT ACCESS AND DECREASING WAIT LIST MORTALITY P. Witkowski1, J. Byam1, A. Desai2, H. Te2, A. Arohnson2, M. Millis1, J. Renz1 ; 1University of Chicago, Chicago, IL; 2University of Chicago, Chicago, IL

SUNDAY

59

PROOF 4

9:30 - 10:30 am Special lecture: how Many hPB Surgeons do we Need? results From a National Workforce Survey. Rebecca Minter Room: Ocean Tower 1 B

10:30 AM - 12:30 PM PARAllEl ABSTRACT PRESEnTATIonS

long oral ii-e - liver iiRoom: Ocean Tower 1 AModerators: Ajay Maker & Pamela Hodul

Mini oral B - Pancreas/BiliaryRoom: Ocean Tower I CModerators: Steven Behrman & Purvi Parikh

long oral ii-e - liver iiRoom: Ocean Tower 1 A

O2-E.01 IMPACT OF PERIOPERATIVE BEVACIZUMAB ON SURVIVAL IN PATIENTS WITH RESECTED COLORECTAL LIVER METASTASES: AN ANALYSIS OF LIVERMETSURVEY Z. Rong1, G. Martel1, F. Vandenbroucke-Menu1, R. Adam2, R. Lapointe1 ; 1HPB Surgery And Liver Transplantation Unit, Hal Saint-Luc, Universite Montr, Montreal, QC; 2Hepatobiliary Center, Hal Paul Brousse, Villejuif, CEDEXdiscussant: Shailesh V. Shirkhande

O2-E.02 ELEVATED RISK OF BILE LEAK FOLLOWING HEPATIC RESECTION AMONG PATIENTS EXPOSED TO BEVACIZUMAB B. D. Nath1, S. Tizio1, L. Mazer1, T. S. Kent1, A. J. Moser1, S. R. Johnson2, D. W. Hanto1 ; 1Beth Israel Deaconess Medical Center, Boston, MA; 2St. Elizabeth’s Medical Center, Brighton, MAdiscussant: Pamela J. hodul

O2-E.03 PROGNOSTIC LIMITATIONS OF THE CLINICAL RISK SCORE: A CONDITIONAL SURVIVAL ANALYSIS IN PATIENTS WITH COLORECTAL LIVER METASTASIS M. Tan1, J. M. Butte1, M. Gonen1, Y. Fong1, P. J. Allen1, T. Kingham1, R. P. DeMatteo1, W. R. Jarnagin1, M. I. D’Angelica1 ; 1Memorial Sloan-Kettering Cancer Center, New York, NYdiscussant: Thomas aloia

O2-E.04 COMPUTED TOMOGRAPHY PREDICTORS OF CHEMOEMBOLIZATION-INDUCED HEPATOCELLULAR CARCINOMA TUMOR NECROSIS M. K. Bryant1, D. P. Dorn1, J. Zarzour1, J. K. Smith1, D. T. Redden1, S. Saddekni1, A. Kamel1, S. H. Gray1, D. E. Eckhoff1, D. A. DuBay1 ; 1University of Alabama At Birmingham, Birmingham, ALdiscussant: Peter Kingham

O2-E.05 RIGHT TRISECTONECTOMY WITH ANTERIOR APPROACH AND HANGING MANEUVER. J. Pekolj1, L. Yazde1, S. Rochet1, G. Del Valle1, E. De Santibasup>1 ; 1HPB Surgery And Liver Transplant Unit. Hospital Italiano De Buenos Aires, Buenos Aires, BUENOS AIRES

O2-E.06 PREDICTORS OF MORBIDITY AND MORTALITY AFTER HEPATECTOMY IN ELDERLY PATIENTS: ANALYSIS OF 7,621 NSQIP PATIENTS C. D. Tzeng1, S. A. Curley1, J. N. Vauthey1, T. A. Aloia1 ; 1The University of Texas MD Anderson Cancer Center, Houston, TXdiscussant: carlos corvera

O2-E.07 ALTERED LYSOPHOSPHATIDIC ACID RECEPTOR EXPRESSION DURING HEPATIC REGENERATION K. A. Simo1, E. M. Hanna1, K. J. Thompson1, D. J. Niemeyer1, A. L. Eheim1, E. Sokolov1, D. Sindram1, D. A. Iannitti1, I. H. McKillop1 ; 1Carolinas Medical Center, Charlotte, NCdiscussant: Bryan clary

O2-E.08 THE EFFECT OF CHEMOTHERAPY ON THE SHORT TERM OUTCOME OF LIVER RESECTION - A COMPARISON OF NO CHEMOTHERAPY VERSUS CONVENTIONAL CHEMOTHERAPY VERSUS BIOLOGICAL AGENTS G. c. Ndlovu1, s. iosifidou1, G. E. Bond-Smith1, R. R. Hutchins1 ; 1Barts And The London HPB Unit, London, ENGLANDdiscussant: Brendan c. Visser


SUNDAY

60

13th Annual Meeting


Mini oral B - Pancreas/BiliaryOcean Tower 1 C

MO-B.01 THE IMPACT OF PYLORUS-RESECTING PANCREATICODUODENECTOMY-THE SHORT AND LONG TERM OUTCOMES IN A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL- M. Kawai1, M. Tani1, S. Hirono1, K. Okada1, M. Miyazawa1, A. Shimizu1, Y. Kitahata1, M. Ueno1, S. Hayami1, H. Yamaue1 ; 1Second Department of Surgery, Wakayama Medical University, Wakayama, WAKAYAMA

MO-B.02 EXTENDED NEOADJUVANT CHEMOTHERAPY FOR BORDERLINE RESECTABLE PANCREATIC CANCER DEMONSTRATES PROMISING POSTOPERATIVE OUTCOMES AND SURVIVAL J. B. Rose1, F. Rocha1, A. Alseidi1, T. Biehl1, R. Moonka1, J. Ryan1, B. Lin2, V. Picozzi2, S. Helton1 ; 1Virginia Mason Medical Center - Department of Surgery, Seattle, WA; 2Virginia Mason Medical Center - Department of Hematology/Oncology, Seattle, WA

MO-B.03 PANCREATIC NEUROENDOCRINE TUMORS: TUMOR SIZE, RADIOLOGIC FEATURES, AND ASSOCIATED HIGH RISK FACTORS S. L. Koonce1, J. A. Stauffer1, D. L. Eck1, H. J. Asbun1, . ; 1Mayo Clinic Florida, Jacksonville , FL

MO-B.04 HETEROGENEITY OF PANCREATIC CANCER ASSOCIATED FIBROBLASTS H. L. Beal1, Q. Dai1, J. E. Shea1, C. L. Scaife1,2, M. A. Firpo1,2, S. J. Mulvihill1,2 ; 1Department of Surgery, Slat Lake City, UT; 2Huntsman Cancer Institute, Salt Lake City, UT

MO-B.05 EVOLUTION OF ROBOTIC SURGICAL TECHNIQUE: THE LEARNING CURVE OF ROBOTIC ASSISTED PANCREATICODUODENECTOMY B. A. Boone1, M. Daouadi1, M. Zenati1, A. Moser2, D. L. Bartlett1, H. J. Zeh1, A. Zureikat1 ; 1University of Pittsburgh Department of Surgery, Pittsburgh, PA; 2Beth Israel Deaconness Medical Center Department of Surgery, Boston, MA

MO-B.06 NATIONAL TRENDS OF PANCREATIC CYSTIC LESIONS OVER AN 18-YEAR PERIOD E. Vega1, S. Varadarajulu2, R. Hawes2, S. Eubanks1, P. Arnoletti1, S. G. De La Fuente1 ; 1Florida Hospital, Division of Surgical Oncology, Orlando, FL; 2Florida Hospital, Division of Gastroenterology, Orlando, FL

MO-B.07 THE USE OF SYSTEMIC ANTICOAGULATION IS SAFE IN PATIENTS UNDERGOING CURATIVE RESECTION OF PANCREATIC DUCTAL ADENOCARCINOMA A. B. Cooper1, R. M. Thomas1, D. S. Kwon2, M. H. Katz1, P. W. Pisters1, J. Vauthey1, J. E. Lee1, J. B. Fleming1 ; 1University of Texas MD Anderson Cancer Center, Houston, TX; 2Henry Ford West Bloomfield Hospital, West Bloomfield, MI

MO-B.08 A NOVEL THERAPEUTIC (SIGMA-2/SMAC CONJUGATE) EFFECTIVELY TARGETS APOPTOSIS IN PANCREAS ADENOCARCINOMA Y. M. Hashim1, D. Spitzer1, S. Vangveravong1, R. Mach1, W. Hawkins1 ; 1Washington University School of Medicine In St Louis, Department of Surgery, St. Louis, MO

MO-B.09 PREDICTORS OF INITIATION AND COMPLETION OF ADJUVANT THERAPY AFTER SURGICAL RESECTION FOR PANCREATIC ADENOCARCINOMA L. M. Mazer1, C. M. Vollmer2, M. P. Callery1, T. S. Kent1 ; 1Department of Surgery Beth Israel Deaconess Medical Center, Boston, MA; 2HUP Dept of Surgery, Philadelphia, PA

MO-B.10 INDICATION OF SURGICAL RESECTION FOR BRANCH DUCT TYPE IPMN S. Hirono1, M. Tani1, M. Kawai1, K. Okada1, M. Miyazawa1, A. Shimizu1, Y. Kitahata1, M. Ueno1, S. Hayami1, H. Yamaue1 ; 1Wakayama Medical University, Wakayama, WAKAYAMA

MO-B.11 OPERATIVE COMPLICATIONS ASSOCIATED WITH NON-THERAPEUTIC LAPAROTOMY IN PATIENTS WITH UNRESECTABLE PANCREATIC CANCER P. M. Spanheimer1, A. R. Cyr1, J. R. Howe1, J. J. Mezhir1 ; 1University of Iowa Hospitals And Clinics, Iowa City, IOWA

MO-B.12 SERUM IGFBP2 AND MSLN AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR PANCREATIC ADENOCARCINOMA R. C. Repko1, Z. W. Kendrick1, M. A. Firpo1,4, C. L. Scaife1,4, D. G. Adler2,4, K. M. Boucher3,4, S. J. Mulvihill1,4 ; 1Department of Surgery, Salt Lake City, UT; 2Division of Gastroenterology And Hepatology , Salt Lake City, UT; 3Department of Oncological Sciences , Salt Lake City, UT; 4Huntsman Cancer Institute, Salt Lake City, UT

SUNDAY

61

PROOF 4


Mini oral B - Pancreas/Biliary - Continued

MO-B.13 A COMPARISON OF PANCREATICODUODENECTOMY TO TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA A NATIONAL SURGICAL QUALITY IMPROVEMENT PROJECT ANALYSIS N. H. Bhayani1, J. L. Miller1, E. Kimchi1, G. Ortenzi1, K. F. Staveley-OCarroll1, N. J. Gusani1 ; 1Section of Surgical Oncology, Department of Surgery, Penn State Hershey Cancer Institute, Hershey, PA

MO-B.14 ENDOSCOPIC DRAINAGE IS A SAFE AND EFFECTIVE INITIAL MANAGEMENT OF SELECTED PANCREATIC PSEUDOCYSTS C. Luu1, J. Velasquez1, B. E. Stabile1, B. Lee1 ; 1Harbor-UCLA Medical Center, Torrance, CA

MO-B.15 CYTOLOGIC ATYPIA AND CANCER-ASSOCIATED MUTATIONAL CHANGES IN CYTOCENTRIFUGATION SUPERNATANT FLUID L. Freed1, B. Corcoran1, J. Bleicher1, V. Stearns1, S. Jackson1, E. Ellsworth1, S. Finkelstein1,2 ; 1RedPath Integrated Pathology, Pittsburgh, PA; 2Department of Pathology, Drexel University, Philadelphia, PA

MO-B.16 EFFECT OF ALCOHOL ON DEVELOPMENT AND PROGRESSION OF SEVERE ACUTE PANCREATITIS (SAP) IN EXPERIMENTAL RAT MODELS E. M. Hanna1, I. H. McKillop1, K. J. Thompson1, D. M. Foureau1, J. B. Martinie1, D. A. Iannitti1, D. Sindram1 ; 1Carolinas Medical Center, Charlotte, NC

MO-B.17 PROGRESSION AND MANAGEMENT OF ADVANCED DUODENAL POLYPOSIS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS P. Serrano1, D. Kim1, R. Grant1, G. May1, P. Kortan1, T. Berk1, H. Al-Ali1, S. Gallinger1 ; 1University of Toronto, Toronto, ON

MO-B.18 EFFECT OF EXTERNAL BEAM RADIOTHERAPY ON SURVIVAL IN SURGICALLY RESECTED GALLBLADDER ADENOCARCINOMA A PROPENSITY SCORE MATCHED SEER ANALYSIS O. Hyder1, T. Sachs1, S. Mayo1, J. Herman1, T. M. Pawlik1 ; 1Johns Hopkins Hospital, Baltimore, MD

MO-B.19 PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE: FIRST CHOICE OR SECOND CHOICE FOR PREOPERATIVE BILIARY DRAINAGE OF HILAR CHOLANGIOCARCINOMA? J. K. Wiggers1, J. J. Kloek1, E. A. Rauws1, K. P. Van Lienden1, O. R. Busch1, D. J. Gouma1, T. M. Van Gulik1 ; 1Academic Medical Centre, Amsterdam, NOORD-HOLLAND

MO-B.20 PREDICTING GANGRENOUS CHOLECYSTITIS: WHO SHOULD OPERATE? B. Wu1, H. Ferdosi1, T. Buddensick1, A. Sautter1, H. Shaukat1, R. Faugue1, M. Siddique1, F. Kamangar2, D. M. Narducci1, G. N. Sulkowski1, G. Kowdley1, S. C. Cunningham1 ; 1Saint Agnes Hospital, Baltimore, MD; 2Morgan State University, Baltimore, MD

12:30 pm closing address: President William c. chapmanRoom: Ocean Tower I ADrawing for complimentary 2014 Meeting Registration


SUNDAY

62

HPBOFFICIAL JOURNAL OFIHPBA, AHPBA AND E-AHPBA

EDITOR-IN-CHIEF: Professor O. James Garden

Have you discovered the HPB Virtual Journal Club?The Virtual Journal Club provides an easy and enjoyable method for learning about a key HPB topic, and features a series of recent articles on the chosen topic accompanied by Learning Objectives around which discussion can be centred.

If you haven’t already discovered the HPB Virtual Journal Club why not explore it today and use it to form the base of your next Journal club discussion.

www.hpbjournal.com

VIRTUAL

JOURNAL CLUB

HSJ-12-40347_HPB VI Filler_5.5"x8.5"_PRF1.indd 1 18/12/2012 16:08

PROOF 4

exhibit hall

New This Year!

Video Presentations

Area

vISIt Our MeDAl-level SPONSOrS!


Exhibitors

64

13th Annual Meeting

booth #12AnGIoDynAMICS14 Plaza DrLatham, NY 12110978-988-1100978-988-1128

AngioDynamics provides minimally invasive medical devices to professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. More information is available at www.AngioDynamics.com.

booth #18BAyER HEAlTHCARE / onyX PHARMACEuTICAlS 250 Ridge RoadDayton, NJ 08810732-274-2000 x 301732-274-2417

Bayer HealthCare and Onyx Pharmaceuticals are committed to cancer research and treatment options. We continually apply our experience, knowledge and passion to develop new cancer therapies.

booth #4 & 5BIoCoMPATIBlES, InC.115 Hurley Road, Building 3Oxford, CT 06478203-262-4198 x 3109203-262-6314

Biocompatibles, with its heritage of leadership and innovation in interventional oncology, is now a BTG International group company. We are investing in product development and clinical trials to deliver on a shared vision of excellence in interventional medicine.

booth #3BK MEDICAl8 Centennial DrivePeabody, MA 01960978-326-1300509-272-0452

The Flex Focus 800 premium ultrasound system from Analogic’s BK Medical is tailored specifically to the surgical suite. It is small, lightweight, supporting a comprehensive range of sterilizable transducers, and can be battery powered.

booth #8CAREFuSIon1500 Waukegan RoadMcGaw Park, IL 60085847-473-7576847-473-7782

CareFusion delivers clinically proven products and services that measurably improve the productivity and safety of healthcare globally. The Pleurx® catheter system is the easy-to-use and effective choice for the home Management of recurrent pleural effusions and malignant ascites. With the PlerX In-dwelling catheter and vacuum bottles, patients can manage fluid accumulation through intermittent drainages at home, with minimal physician intervention.

booth #6ElSEVIER, InC.1600 JFK Blvd. - Suite 1800Philadelphia, PA 19103215-239-3491215-239-3494

ELSEVIER is a leading publisher of health science publications, advancing medicine by delivering superior reference information and decision support tools to doctors, nurses, health practitioners and students With an extensive media spectrum - print, online and handheld, we are able to supply the information you need in the most convenient format.

Exhibitors

65

PROOF 4

booth #22ERBE uSA2225 NW ParkwayMarietta, GA 30067770-955-4400770-955-2577

ERBE, with over 160 years developing innovative technologies for surgery, presents the ERBEJET®2. A unique water-jet dissector for the separation and aspiration of water-soluble tissue, that tends to spare fibrin rich structures such as vessels and ducts and provides accurate dissection with minimal trauma to surrounding tissue.

booth #13, 14, 15 & 16ETHICon EnDo-SuRGERy4545 Creek RoadCincinnati, OH 45242513-337-7286513-337-4764

EES Energy Boilerplate for Medical Meeting Program Directories. Ethicon Endo-Surgery, a Johnson & Johnson company, develops and markets energy devices that are gentle on surrounding tissue for a variety of procedures across Bariatric, Colorectal, ENT, General, Gynecologic, Orthopedic, Plastic and Thoracic specialties. Ultrasonic HARMONIC® technology offers a unique combination of precision and multifunctionality. And ENSEAL® technology offers devices that are strong on sealing. More information on the company can be found at www.ees.com.

booth #7HITACHI AloKA MEDICAl10 Fairfield Blvd.Wallingford, CT 06492203-269-5088203-269-6075

Hitachi Aloka Medical’s commitment to ultrasound for surgeons offers a wide range of consoles and specifically designed transducers to meet the needs of every surgeon.

booth #21InTEGRA311 Enterprise DrivePlainsboro, NJ 08536609-275-0500609-799-3297

Integra is a leader in neurosurgery, offering a vast portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and critical care.

booth #19 & 20InTuITIVE SuRGICAl1266 Kifer RoadSunnyvale, CA 94086408-523-7552

Intuitive Surgical, Inc. is the global technology leader in robotic-assisted, minimally invasive surgery. The Company’s da Vinci® System enables general surgeons to offer a minimally invasive approach - even to patients with complex conditions.

booth #1 & 2MEDTRonIC180 International DrivePortsmouth, NH 03801603-848-9659

Medtronic Advanced Energy products deliver proprietary Transcollation technology, a combination of radiofrequency energy and saline that provides hemostatic sealing of soft tissue during a wide variety of surgical procedures.


Exhibitors

66

13th Annual Meeting

booth #9PATHFInDER TECHnoloGIES2969 Armory Drive Suite 100ANashville, TN 37204847-420-2339615-783-0554

Pathfinder Technologies offers computer-assisted navigation for enhanced visualization to enable medical professionals to deliver optimal therapies to the target anatomy with precision and efficiency.

booth #11RED PATH InTEGRATED PATHoloGy2515 Liberty AvePittsburgh, PA 15222412-224-6100412-224-6110

RedPath is a molecular diagnostics laboratory focused on providing the most advanced clinical testing to clinicians. Our patented PathFinder TG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemas.

booth #17SIRTEX MEDICAl InC.300 Unicorn Park DriveWoburn, MA 08101888-474-7839978-229-9585

SIR-Spheres® microspheres is the first and only, fully FDA-approved radiolabeled product for the treatment of metastatic colorectal cancer Available at more than 500 treatment centers, over 25,000 doses of SIR-Spheres microspheres have been supplied worldwide.

booth #10THoMPSon SuRGICAl InSTRuMEnTS10170 E. Cherry Bend RoadTraverse City, MI 49684231-922-5178231-922-0174

Exhibitors

67

PROOF 4

ihPba / kenneth Warren foundation donorsWe are proud to recognize our donors and would like to thank all of the Organizations and Individual Supporters whose continued generosity allows us to promote the research on diseases of the liver, pancreas and biliary tract.

international life circleThomas Warren Wiley Blackwell, Inc.

research steWards circle Americas Hepato-Pancreato-Biliary Association (AHPBA)International Hepato-Pancreato-Biliary Association (IHPBA)

O. James GardenC. Wright PinsonSally Warren

leadersAsian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA)Markus BüchlerJohn L. Cameron

European-African Hepato-Pancreato-Biliary Association (E-AHPBA)Carlos Fernandez-del CastilloDirk Joan GoumaW. Scott Helton

Joan E. KolliganJoseph W.Y. LauYuji NimuraHenry A. PittJames ToouliGeorge Warren

benefactorsMichael D’AngelicaJacques Belghiti

William R. JarnaginGlenn Steele

Jean-Nicolas VautheyJohn Albert Windsor

sPonsorsClem ImrieYoshifumi Kawarada

Satoshi KondoSean Mulvihill

Steven StrasbergAtushi Sugioka

friendsEduardo Akaishi

Mohammed Alsaghier

Adnan Alseidi

Taku Aoki

Gerard Aranha

Takehide Asano

Christoph Ausch

Martine Azagra-Goergen

Telesforo Bacchella

Claudio Bassi

Shantanu Basu

Giulio Belli

Neil Anthony Berry

Syryabhan Bhalerao

Andrew Biankin

Giulio Belli

Giovanni Antonio Bonilla

Christoph Broelsch

Iain Cameron

Jorge Leon Celsi

Matteo Cescon

Eddy Hok Chin Chan

John W. Chen

Stanley Chen

Zhibin Cheng

Daniel Cherqui

Chol-Kyoon Cho

Roland Montenegro Costa

Raul Cutait

Eduardo de Santibanes

Horacio D’Agostino

Bobby Dasari

Mark Deakin


AHPBA 2013

68

13th Annual Meeting

Cornelis Dejong

Rajendra Desai

Elijah Dixon

Paul Michael Dolan

Marcelo Enne

Jonathan Fawcett

Evangelos Felekouras

Carlos Fernandez-Del Castillo

Daniel Figueroa-Tentori

Craig Fischer

Carlos Florez-Zorilla

Yiliam Fundora

Eldar M. Gadzijev

Steven Gallinger

Dieter Jose Garcia

Kleanthis Giannoulis

Jean-Francios Gigot

Georgios Glantzounis

Mehmet Haberal

Ellen Hagopian

Ho-seong Han

Ulrich Hopt

Arild Horn

Thomas Howard

Thomas Hugh

Oscar Imventarza

Palepu Jagannath

Razman Bin Jarmin

Timoleon Kakavoulis

Santeev Kanoria

Basil P. Kekis

Chen-Guo Ker

Mustafa Kerem

Wolfram Trudo Knoefel

Valery Kubyshkin

Nobuaki Kurauchi

Paul Lada

Roberto Lauro

Sunggyu Lee

Mickael Lesurtel

Richard Letourneau

Kam Fung Leung

Jun Li

Michael Ka Wah Li

Marcel Machado

Sameer Mihrshahi

Paulo Mira

Kohji Miyazaki

Michele Molinari

Frank G. Moody

Mariano Moro

Gareth Morris-Stiff

Jorge Antonio Mosquera

Satvinder Mudan

Akimasa Nakao

David Nagorney

Leslie Nathanson

John P Neoptolemos

Overgaard Nielson

Yuji Nimura

Gregory Nolan

Peter David Nottle

Adianto Nugroho

Shinji Osada

Karl-Joseph Paquet

Maris Pavars

Zbigniew Puchalski

Stefano Puleo

Guntars Pupelis

Renyi Qin

Sadasivan Ramalingam

Samuel Ramos Linaje

Alvarao Riart

Khunpugdee Saipan

Robert Sammartano

Wayne H. Schwesinger

Markus Selzner

Norbert Senninger

Yan-Shen Shan

Harjit Singh

Ross C. Smith

Dinananth Sonar

Karl Sondenaa

David Stell

Michael Stephen

Cheng-hsi Su

Miguel Angel Suarez Munoz

Atsushi Sugioka

Mounib Tacla

Shin Takasaki

Sumihito Tamura

Masao Tanaka

Pavel Tarazov

Hirtaka Tashiro

Jorge H. Tobar de Leon

Guido Torzilli

Evangelos C. Tsimoyiannis

Ajay K. Upadhyay

Atsushi Urakami

Thomas van Gulik

Tjarda van Heek

Dionisios Vrochides

Toshifumi Wakai

Andrew Warshaw

J. Anthony Williams

Robin Williamson

Thomas Wilson

Errawan Wiradisuria

Cheng-Chung Wu

Hongqiang Yang

Euripedes Yettmis

Keisuke Yoshida

Xu-ting Zhi

Krzysztof Zieniewicz

Annual Meeting

69

AHPBA 2014

MAKE YOUR PLANS

FOR NEXT YEAR

March 12-16, 2014

Eden Roc Renaissance M i a M i B e ac h , F l o r i da

13th Annual Meeting

sPeakers, moderators, discussantsThe following Speakers/Moderators/Discussants provided information to be disclosed.

Kevin CharpentierAngiodynamicsRole - Speaker/Lecturer/Meeting participantData Safety Monitoring BoardReceived - Ownership interestResearch Grant

David GellerMedtronicRole - Board Member/Officer/TrusteeReceived - Ownership interest

Chet HammillPathfinderRole - Member on advisory committees or review panelsReceived - Ownership interest

William HeltonLifecell CorpRole - Board Member/Officer/TrusteeReceived - Ownership interestReceived - Other

Alan HemmingBayerRole - OtherReceived - Ownership interest

David LinehanPfizerRole - Speaker/Lecturer/Meeting participantReceived Royalty - Research FundingResearch Funding

Martin MartinAngiodynamicsRole - Member on advisory committees or review panelsReceived - Ownership interest

Flavio RochaCovidienRole - OtherReceived - Other

Roderich SchwarzVartis, GenentechRole - Board Member/Officer/TrusteeReceived - Other

Charles ScogginsEthicon EndosurgeryRole - Member on advisory committees or review panelsRole - Board Member/Officer/TrusteeReceived - Ownership interestReceived - Other

Disclosures

71

PROOF 4

abstract authorsThe following Abstract Authors provided information to be disclosed.

George BerciKarl Storz Endoscopy

Received Salary And Grant Support.Role - Consultant/AdvisorReceived - SalaryReceived - Horaria

Joseph BuellEthicon

Consultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

CovidienConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

BaxterConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

AppliedConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

EthiconConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

CovidienConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

BaxterConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

AppliedConsultant And TrainerRole - Consultant/AdvisorReceived - Consulting Fee

Sricharan ChalikondaIntuitive Surgical.

Role - Consultant/AdvisorReceived - Consulting Fee

Eric EllsworthRedPath Integrated Pathology

Role - EmploymentReceived - Salary

Sydney FinkelsteinRedPath Integrated Pathology

Role - EmploymentRole - Management positionRole - Board Member/Officer/

TrusteeReceived - SalaryReceived - Ownership interest

Real LapointeSafi-Adventis

Speaker’s And Conference HorariaReceived - Horaria

RocheSpeaker’s And Conference HorariaReceived - Horaria

Mark LybikRedPath Integrated Pathology

Role - InvestigatorReceived Other: RedPath Provided Financial Support To Northside Gastroenterology For Data Collection In This Study

Robert Calvin Grier Martin IIAngiodynamicsSenior Author Is A Consultant For Company Who Manufactures The Device Used In The StudyRole - Consultant/AdvisorReceived - Consulting Fee

A. James. MoserBayer

Techlogy ConsultantRole - Consultant/AdvisorReceived - Consulting Fee

IntuitiveTechlogy ConsultantRole - Consultant/AdvisorReceived - Consulting Fee

Bayer, IntuitiveRole - Consultant/AdvisorReceived - Consulting Fee

Marlies SharkhawyBaxter Healthcare Corp.EmployeesRole - EmploymentReceived - SalaryReceived - Ownership interest

Ann-Marie TerryRedPath Integrated PathologyRedPath Is A Reference Lab That Offers Molecular Diagstic Testing.Role - EmploymentReceived - Salary


Disclosures

72

*AngioDynamics, the AngioDynamics logo, StarBurst, NanoKnife and Acculis are trademarks and/or registered trademarks of AngioDynamics, Inc., an affi liate or a subsidiary. Legal Manufacturer: Microsulis Medical, Ltd., Parklands Business Park, Denmead, Hampshire UKRefer to individual product Instructions and/or User Manual for Indications for Use, Contraindications, Warnings and Precautions.CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. © 2013 AngioDynamics, Inc. MLC 507 US Rev A

We don’t compete with othertechnologies, we offer them.

Microwave

Now offering the full range of ablation technologies.

Visit AngioDynamicsbooth #12 to learn more

Microwave Tissue Ablation System

[[

AMERICAS HEPATO-PANCREATO-BILIARY ASSOCIATION … · 2018-07-08 · session organized by Sharon...

Documents

Transcript of AMERICAS HEPATO-PANCREATO-BILIARY ASSOCIATION … · 2018-07-08 · session organized by Sharon...